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1. Introduction 
Cardiovascular diseases are considered as the major health problem responsible for about 
30% of the global death [1,2,3]. The high prevalence rate of cardiac diseases and the 
associated critical case of the patient entailed innovative treatment. Using cardiovascular 
prostheses, the damaged functions and consequently the patient`s life quality were 
significantly improved. The surgeons have turned to prosthetic grafts mostly made from 
polymeric or metallic materials to hold the graft long-term patency because of lack of 
suitable autologous grafts, while the biodegradable implantable grafts are applied to 
disappear after performing their purposed function [1-3]. However, polyethylene 
terephthalate, PET (Dacron®) textiles are preferably utilized to replace the damaged blood 
vessels and for artificial heart valves in order to restore the normal blood flow and cardiac 
output.   
 
Fig. 1. Cardiovascular devices of PET textile. Covering the stent graft (A), branched vascular graft (B), 
surgical meshes(C), and covering the sewing rings of artificial heart valves (D). 
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Utilization of PET graft was historically of the most interest as DeBakey and Julian firstly in 
1957 employed it to repair different vascular defects [3,4], followed by implantation of 
artificial heart valve in 1960 which increased into approximately 325,000 valve replacements 
worldwide every year, with a reported market sales of about 1.45 $ billion [5]. 
Currently, PET textiles with various configurations are available for many medical devices to 
support and ensure the desired performance and stability (Fig.1). Nonetheless, a grafts 
failure is also associated although most medical PET grafts satisfactorily work. Individually, 
this may be dependent on the age of the patient, lifestyle, medical history, body chemistry, 
and the graft properties.  Importantly, the graft-associated infection, in addition to the  
thrombogenic properties of PET trigger a variety of adverse reactions in the host, and 
activate a number of biological cascades that display various complications mainly; tissue 
inflammation, and formation of fibrotic tissue around the graft which are the leading case 
for grafts failure and reoperation, increasing both the risk to patients and the cost of health 
care [3,6,7]. Accordingly, the necessity to biocompatible and infection-resistant graft is still 
one of the most challenges that encouraged us to improve the properties of cardiovascular 
PET grafts in objective to enhance the grafts long-term patency and patient`s life quality.  
 
2. Synthetic polymeric prostheses are the gold standard for cardiovascular grafts 
The auto natural bypasses grafts (patient`s own) such as saphenous veins or mammary 
arteries were used to treat the damaged vessels. However, about one-third of the patients 
don`t have veins suitable for grafting owing to previous vascular disease or vein stripping. 
Additionally, limited success was reported with patency rates generally ranging between 50-
70% due to dimension restrictions, mechanical property mismatch, and disjunction at the 
anastomosis associated with significant morbidity and surgical costs [8-11].  Hence, the 
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synthetic polymeric grafts have been investigated and demonstrated a superior success. 
Mostly PET textiles are become gold standard for cardiovascular grafts in clinical practice 
due to its excellent mechanical properties, good healing features, nontoxic, strong with 
sufficient flex and tensile strength. In addition, the PET tendency to dilate over time makes it 
the best choice for long-term use in-vivo. The most permanent PET grafts are applied to 
replace the large diameter arterial vessels and covering the sewing rings of heart valves and 
vascular stent, based on its highly flexible mechanical feature, and its micro-porous wall 
structure which hold promise for enhanced healing, suture retention, and compression 
resistance [5,12]. 
 
3. Woven and knitted forms of Crimped PET are the most successful cardiovascular grafts  
Firstly in 1950, DuPont developed PET and patented its widely known name Dacron® fibers. 
Currently, ten PET configurations are available in clinical use with high reported rates of 
success for woven and knitted configurations [2,4] (Fig.2). The multifilament PET threads in 
woven form are fabricated in an over-and-under pattern resulting in very limited porosity 
and minimal creep of the finished graft. While PET threads in knitted form are looped to 
create greater porosity and radial distensibility. The velour technique that extends the loops 
of yarn on the surfaces of the fabrics has been used in an attempt to increase tissue 
incorporation. Moreover a crimping technique is utilized to increase the flexibility, 
distensibility, and kink-resistance of textile grafts. Finally, prosthetic rings or coils are applied 
to the external surface of the grafts as external support to resist kinking and possible 
mechanical compression [2,4]. 
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Fig. 2. SEM micrographs of woven (A) and knitted (B) forms of crimped PET grafts. The multifilament 
PET threads in woven form are fabricated in an over-and-under pattern, while they are looped in 
knitted form. The crimped technique, shown in picture, is utilized to increase the flexibility, 
distensibility, and kink-resistance of grafts. 
 
4. The thrombogenic property of PET restricted the grafts patency 
The extended stability of PET over 10 years without significant deterioration offers 
advantages to medical applications as non-degradable implantable graft [14].  Nevertheless, 
one of the prominent shortcomings of PET is the intrinsic thrombogenic property that 
impaired ultimately the long-term patency of the graft and hence, the patient`s life quality. 
However, the development of the host response depends on the intrinsic properties of the 
graft itself and the hemodynamic environment in which the graft is placed [15].  
 
5. Host response 
5.1. Initial tissue damage leads to thrombin formation and platelets aggregation 
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It is unavoidable to damage the tissue during implantation of medical graft. The initial injury 
of surrounding tissue initiates complex series of biological and biochemical cascades [16,17] 
(Fig.3). The coagulation cascade and platelets aggregation are triggered by blood contact 
with collagen in the sub-endothelial tissue. The coagulation cascade submits ultimately 
thrombin which hydrolyses fibrinogen and forms the fibrin network. Likewise, activation of 
platelets contributes to coagulation by secretion of pro coagulant factors. This event is 
essential for the healing of damaged tissue, because the activated platelets also release 
many proteins participate in the healing. Moreover, the release of interleukin 8 (IL8), and 
macrophage inflammatory protein 1 alpha (MIP1α) from the activated platelets attracts and 
activates the macrophages leading to initiation of the inflammatory response [16-18]. 
 
5.2. The host recognizes the graft as being foreign after fibrinogen adsorption on grafts 
surface 
Upon implantation of a graft, serum proteins such as IgG and the complement factors adsorb 
physically on the grafts surface (Fig.3). The adsorbed proteins act as chemo attractants and 
hence accelerate the migration of neutrophils and monocytes towards the implanted graft 
[16-18]. Furthermore, the interaction of fibrinogen with grafts surface leads to conformation 
of fibrinogen into more energetically favorable form, thereby exposing the occult epitopes 
P1 (γ 190-202) and P2 (γ3727-395). Presence of these epitopes on the grafts surface displays 
an essential role in the development of the inflammatory response as they will be 
recognized by the neutrophils. Through this mechanism, the body will recognize the graft as 
being foreign and will subsequently attempt to remove it. In the case of non-degradable 
graft, the body cannot digest the graft instead a chronic inflammatory response and a 
fibrous capsule are developed around the graft (Opsonization) [16-18].  
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5.3. The activated neutrophils excrete chemo attractants and accelerate the monocytes 
migration towards the implantation site 
Neutrophils are the predominant cell type during the acute inflammatory response. The 
soluble complement factors formed on the grafts surface along with fibrinogen and fibrin 
attract and accelerate the migration of neutrophils towards the implantation site initiating 
the acute inflammation (Fig.3). Subsequently, the activated neutrophils secrete the most 
important chemo attractant IL8 that enhances their own recruitment, In addition to 
macrophage inflammatory protein 1 (MIP-1α) which accelerates the monocytes migration 
towards the implantation site. Moreover, the released histamine from mast cell increases 
the vascular permeability in the surrounding tissue and attracting monocytes [16-18]. 
Consequently the attracted monocytes adhere and differentiate into macrophages, and 
secrete many factors which contribute in the inflammatory progresses [16-18]. 
 
5.4. Foreign body giant cells are formed as a response to non-biodegradable graft 
The macrophages attempt to remove the foreign graft from the body. Differently, 
depression of macrophages is developed due to resistance of the non-biodegradable graft 
that triggers the formation of foreign body giant cells (FBGCs) (Fig.3). Although the exact 
mechanism of FBGCs formation has not yet been completely explained, macrophage fusion 
on grafts surface depends on the material itself and the absorbed proteins as vitronectin, in 
addition to IL4 and IL13 from mast cells and T-cells. The resulting multinuclear phagocytes 
(FBGCs) secrete reactive oxygen and degradative enzymes and acids in attempt to degrade 
the implanted graft [16-18]. 
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Fig. 3. Host response after graft implantation 
1) Upon implantation, tissue injury initiates the 
release of tissue factor (TF) from sub endothelial 
tissue that triggers the extrinsic coagulation 
pathway leading to activation of thrombin. 
Consequently, fibrin is formed and starts the blood 
clot.  
2) Platelets are activated after contact with 
extracellular matrix proteins and release healing 
factor as soon as thrombin that enhance the 
coagulation cascade and the recovery process. 
3) Plasma proteins and complement factors adsorb 
on the grafts surface directly after implantation, 
and activate the alternative complement pathway 
leading to formation of C3a and C5b responsible 
for monocytes migration towards the implanted 
graft. Other adsorbed plasma proteins; fibrinogen 
and vitronectin, facilitate neutrophils recognition 
and adherence. 
4) The presence of the complement factors along 
with fibrinogen and fibrin at the implant site 
attract and activate neutrophils.  The activated 
neutrophils recognize and adhere onto implanted 
surface by interaction with the adsorbed 
fibrinogen. Subsequently IL8 is released from the 
neutrophils. 
5) Mast cells are activated and release histamine 
after degranulation leading to increase in the 
vascular permeability and attract monocytes. 
6) Monocytes are attracted by histamine and IL8. 
7) Monocytes express the β2 integrin that 
recognize P1/P2 epitopes on the fibrinogen surface 
after conformational change. The monocytes 
adhere to the implant graft and differentiate into 
macrophages. Subsequently, the release of tumor 
necrosis factor (TNF-α), IL6, granulocyte-colony 
stimulating factor (G-CSF), and granulocyte-
macrophage colony stimulating factor (GM-CSF) 
contribute to the amplification of the inflammatory 
response. 
8) Macrophages interact with vitronectin on the 
grafts surface. The released IL4 and IL13 accelerate 
the macrophage fusion leading to formation of 
foreign body giant cells. 
9) The cytokines and growth factor released from 
macrophages and giant cells initiate blood vessel 
formation. 
10) The released proteins from the macrophages 
and giant cells attract connective tissue cells 
(fibroblast) and activate the tissue remodeling. 
Over time, the fibroblast forms a fibrous capsule 
around the graft.
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5.5. Host response is completed by formation of fibrous capsule around the graft 
As a result of the previously described complex events, the tissue surrounding the implanted graft 
will remodel. Fibroblasts become activated by inflammatory proteins and produce new 
extracellular matrix (ECM) proteins contain different subtypes of collagen. The newly formed ECM 
has much more stable cross-linked proteins, resulting in the formation of a fibrous capsule around 
the graft [16-18] (Fig.3).  
 
6. Graft-associated infection is the most substantial challenge after graft implantation 
Graft-associated infection is still the substantial complication after implantation. Infections of 
medical grafts occur despite full sterility during surgical operation and regardless of perioperative 
parenteral antibiotic prophylaxis [19]. Such infections increase the risk of graft failure and 
patient’s death. The morbidity as high as 75% has been reported to graft infection related to; 
Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Pseudomonas aeruginosa, 
and Proteus bacterial strains, which can be introduced into the graft site at the time of 
implantation by preoperative contamination, postoperative wound infection or systemic 
bacteraemia. However, bacteria frequently present in the circulation are in sufficient quantities to 
cause graft infection [20,21]. 
 
7. Bacterial adhesion is the first step of biofilm formation and subsequent infection 
The infection initiates by successful attachment of free, floating bacteria into grafts surface. The 
first colonist adheres to the surface through weak, reversible physical forces (Fig.4), subsequently 
they anchor themselves more permanently using cellular adhesive structures such as pili, and start 
to produce exo-polysaccharides substance (EPS). Afterwards, the cell-cell bridges are developed 
upon stimulation of signal proteins in the bacterial wall to hold irreversibly the bacteria on the 
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grafts surface [22].  The attached bacteria proliferate forming the basic organizational units of 
biofilm. The primary colony accelerates the attachment of other bacterial cells to the EPS, 
resulting in bacterial aggregation and increased production of EPS which forms finally the bacterial 
biofilm. Occupied volume occurs during biofilm maturation due to cell proliferation and 
recruitment associated with formation of water channels and changes in shape and size, before 
the bacterial dissemination occurs and colonize new surfaces [23,24]. The five main steps in 
biofilm formation are schematically illustrated in figure 4. 
 
Fig. 4. Systematic steps of biofilm formation. Initial bacterial attachment (1), bacterial irreversible 
attachment (2), colonization (3), maturation (4), and dispersion (5). 
 
8. Tissue engineering of cardiovascular grafts  
One approach that addresses the problems associated with cardiovascular prostheses is the tissue 
engineering because it offers the possibility of designing a biocompatible graft appropriate for 
long-term patency [25,26]. Tissue engineering has been defined as the persuasion of the body to 
accept the graft by introduction of biomolecules, cells and supporting structures to the proper 
sites of graft [27]. Particularly, tissue engineering of the cardiovascular grafts involves the 
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development of biological substitutes with inherent mechanical, chemical, and morphological 
properties meet the cardiovascular system requirements.  The potential biocompatibility and 
bacterial infection resistance properties of tissue-engineered cardiovascular graft hold promise to 
decrease the risk of grafts rejection. 
 
9. Conclusion and scope of thesis 
PET textile is the gold standard graft mainly employed to cardiovascular applications due to its 
preferable advantages. However, implantation of PET graft is associated with bacterial infections 
and triggers a chronic host response that essentially decreased the grafts patency and necessities 
its replacement. These complications are standing as a tough challenge for many researchers.  In 
this thesis, two different crimped configurations of PET cardiovascular grafts, woven and knitted, 
were modified to minimize the bacterial adhesion and to enhance the biocompatibility. Using 
various ideas and strategies along with different standard methods supported with in-vitro studies 
and statistical data analysis, we present effective approaches to treat the most common 
complications after PET graft implantation in aim to potentially improvement of grafts patency and 
patient`s life quality:  
In chapter 2: A multifunctional network-structured film coat was developed using newly 
synthesized polymer that manifested paramount properties, mostly the bacterial anti-adhesion 
efficiency and biocompatibility. The developed coat maintained the grafts flexibility and folding 
ability. 
In chapter 3: The initial bacterial adhesion was enzymatically inhibited using covalently 
immobilized lysozyme on PET graft to eradicate predominantly Gram-positive bacteria and to 
maintain the biocompatibility of the modified graft. 
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In chapter 4: PLGA nanoparticles were covalently immobilized onto two different cardiovascular 
prostheses namely; woven crimped polyethylene terephthalate (PET, Dacron®) and expanded 
polytetrafluoroethylene (ePTFE, Teflon®) using FITC-dextran as hydrophilic model. 
In chapter 5: Heparin was covalently immobilized to develop thrombus resistant grafts. 
Additionally, collagen was co-immobilized to enhance the host cell compatibility and the long-term 
patency of PET grafts. 
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Abstract 
A multifunctional network- structured film coating of woven and knitted forms of crimped 
polyethylene terephthalate PET graft was developed to hinder graft-associated infections. 
Sulfadimethoxine polyhexylene adipate-b-methoxy polyethylene oxide (SD-PHA-b-MPEO) diblock 
copolymer was employed for coating of previously oxidized PET to acquire negative charge to the 
surface as confirmed by Fourier transform infrared spectroscopy. The network-structured 
topography of the coat was visualized by scanning electron microscopy. The biocompatibility of 
the prepared coat was evaluated by mouse L929 fibroblast cell, in addition to the bacterial anti-
adhesion efficiency against three different broad-spectrum pathogens. Our figures of merit 
revealed that the formed coat showed a porous topographic architecture which manifested 
paramount properties, mostly bacterial anti-adhesion efficiency, biocompatibility with host cells as 
well as maintenance of grafts flexibility and folding ability. Compared to untreated control grafts, 
the number of adhered Gram-positive Staphylococcus epidermidis previously isolated from a 
patient’s vein catheter was decreased by 2.6 and 2.3 folds and of adhered Staphylococcus aureus 
by 2.3 and 2.4 folds for woven and knitted grafts, respectively. Gram-negative Escherichia coli 
demonstrated a reduction by 2.9 and 2.7 folds for woven and knitted grafts, respectively. In 
addition, the adhesion and growth characteristics of L929 cells revealed no significant effect of the 
grafts modification on the biocompatibility. In conclusion, our data suggests that coating of PET 
with (SD-PHA-b-MPEO) is a versatile approach switches the surface into higher hydrophobic and 
negatively charged to offer a synergistic antibacterial effect with improved efficacy.  
 
Keywords: Network-structured coat; Crimped polyethylene terephthalate; Bacterial anti-adhesion. 
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1. Introduction 
Damaged blood vessels or heart valves are usually replaced using polyethylene terephthalate PET 
(Dacron
®
) grafts due to various advantages mainly; tensile ability, strength, stability, and low 
production cost [1,2,3]. Particularly, woven and knitted forms of crimped PET (Fig.1) are mostly 
used to replace the large diameter blood vessels and cover the heart valve swing ring and vascular 
stent [1,2].  
 
Figure 1. SEM micrographs of woven (A) and knitted (B) forms of crimped PET grafts. The multifilaments 
PET threads in woven form are fabricated in an over-and-under pattern, while PET threads in the knitted 
form are looped. The crimped technique, shown in the picture, is utilized to increase the flexibility, 
distensibility, and kink-resistance of grafts. 
 
 
However, so far prosthetic valve endocarditis (PVE) or prosthetic vascular graft infection (PVGI) are 
the leading cause of short-term patency of PET grafts due to their susceptibility to bacterial 
infection and biofilm formation [4-6].  The development of infection starts primarily by bacterial 
adhesion onto the graft surface via weak, reversible, physical forces followed by an adhesion 
cascade to secure successful attachment. The adhered bacteria proliferate and develop an 
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irreversible attachment, forming dense microbial communities called biofilm [7]. Studies on 
pathogenic organisms responsible for PET graft infections have shown that Staphylococcus aureus 
is the infecting organism in ~70% of the cases, while Staphylococcus epidermidis is involved in 
~30% resulting in prolonged hospitalization, graft failure, and patient death [8-9].  
To overcome the aforementioned problems, surface modification of PET by polymer coating for 
drug delivery becomes thus one essential technique for further applications [10,11].The polymer 
film offers the opportunity to load and release various drugs to treat the main complications like 
inflammatory responses [12], thrombosis [13], and bacterial infection [14], while conserving the 
biocompatibility with biological tissues. In theory, casting of a polymeric film onto crimped PET 
grafts could be an ideal strategy to minimize the bacterial infection after implantation [7,11,14]. 
However, this method has severe limitations including relatively limited graft flexibility and ability 
to tensile, which make it difficult to be sutured with the connecting tissues. Additionally, the film 
would be incised when sewing with surrounding tissue which weakens the desired effect of the 
polymer coat.  
Hence, we report a priority to coating of crimped PET grafts by a multifunctional network-
structured film using a newly synthesized, biodegradable polyhexylene adipate-b-methoxy 
polyethylene oxide (PHA-b-MPEO) diblock copolymer. The employed copolymer is composed of a 
hydrophobic (polyhexylene adipate, PHA), and a hydrophilic block (methoxy polyethylene oxide, 
MPEO). For anti-bacterial effectiveness, the negatively charged, pH sensitive sulfadimethoxine 
(SD) moiety was tethered to the copolymer backbone [15] as schematically illustrated in Figure 2.  
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Figure 2. The molecular structure of the amphiphilic SD-PHA-b-MPEO di-block copolymer.  The polymer is 
comprised of the hydrophobic block (polyhexylene adipate, PHA), and the hydrophilic block (methoxy 
polyethylene oxide, MPEO). The sulfadimethoxine (SD) moiety was immobilized to the chain end of the 
polymer backbone for anti-bacterial effectiveness. 
 
The coating process was triggered by previous oxidization of PET surface using piranha solution 
(H2O2/H2SO4) to introduce a negatively charged hydroxyl group on the surface by selective 
cleavage of the ester bond within PET surface. In order to provide an irregular porous patterned 
film we varied humidity of the atmosphere and polymer concentration during the process of film 
formation, and took advantages of the repulsion forces between the modified surface and the 
employed polymer to equip a film that does not closely adhere to the PET surface.  This versatile 
technique allows fabrication of network- structured film that does not tightly adhere to the PET 
surface after polymer casting. The developed film maintains the essential biocompatibility 
requirements and grafts flexibility along with the folding ability and provides the desired local anti-
bacterial effect as schematically illustrated in Figure 3. Notably, the anti-bacterial activity was 
confirmed in-vitro against active human pathogens namely Gram-positive; S. epidermidis and S. 
aureus and Gram-negative; E. coli strains. 
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Figure 3.  The mechanism of the multifunctional network- structured film on bacteria adhesion and host 
cell behavior. The formed coat inhibits the bacterial adhesion due to the negatively charged, bactericidal 
sulfadimethoxine group, and the hydrophobic PHA block, in addition to the bacterial cell-repelling 
characteristics of MPEO block. The hydrophilic properties of MPEO and the formed porous coat enable the 
host cells to bridge the filaments. 
 
2. Material and Methods 
2.1.  Materials 
Woven and knitted forms of crimped polyethylene terephthalate (PET, Dacron
®
) grafts (14 mm 
internal diameter, 30 cm length, 12 filaments per yarn bundle) were kindly provided by Vascutek 
GmbH, Germany. The biodegradable amphiphilic sulfadimethoxine-polyhexylene adipate-b-
methoxy polyethylene oxide (SD-PHA-b-MPEO) diblock copolymer was kindly supplied by Prof. Dr. 
Andreas Greiner, Department of Chemistry, Marburg University, Germany. The bacterial strains; 
Staphylococcus epidermidis (isolated from a vein catheter of a patient), Staphylococcus aureus 
(ATCC 29213), and Escherichia coli (ATCC 25922) were supplied by the Institute for Medical 
Microbiology and Hospital hygiene, Marburg University, Germany. Hydrogen peroxide H2O2 (30%) 
was purchased from Carl Roth GmbH, Germany. The mouse L929 fibroblasts cell line was obtained 
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from DSMZ, Germany. Dulbecco`s modified Eagle´s medium (DMEM), Earle`s Balanced Salt 
Solution (EBSS), gamma irradiated Fetal Bovine Serum (FBS), trypsin, streptomycin, penicillin, and 
amphotericin B were purchased from PAA Laboratories GmbH, Germany. L-glutamine was 
provided by VWR, Germany. All other used chemicals were of analytical reagent grade. 
 
2.2. Methods 
2.2.1. Network-structured film coating  
In the present study, two different forms of crimped PET cardiovascular grafts, woven and knitted, 
as shown in Figure 1, were used for network-structured film coating. All steps in the following 
experiments were performed for each form. 
Firstly, the surface of PET graft was oxidized to acquire a negatively charged hydroxyl group using 
piranha solution composed of H2O2 (30%) and sulfuric acid (97%) at 1:1 v/v.  
Briefly, woven and knitted slices (2x2 cm
2
) of crimped PET were cleaned in 50% ethanol under 
sonication (Sonorex RK 100H, Bandelin, Germany) and then dipped into 20 ml piranha solution at 
25°C for 15 minutes. The grafts were rinsed with distilled water and oven dried at 80°C for 1h. 
Afterwards, the oxidized grafts were dipped for 3h into polymer solution of SD-PHA-b-MPEO in 
dichloromethane (10 mg/ml). The desired network-structured film was then allowed to form by 
solvent evaporation at 25°C in a cap sealed glass chamber under saturated water vapor [16]. The 
obtained graft is abbreviated as PET-Net. For topographic comparison purposes, a polymer film 
was prepared with the same protocol using non-oxidized PET grafts.  In all other described 
experiments, the cleaned, unmodified PET was used as control.  
 
2.2.2. FTIR Analysis 
Fourier transform infrared spectroscopy FTIR (Alpha, Bruker, Germany) was utilized to analyze the 
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oxidized surface of PET after piranha treatment in comparison to unmodified PET. The analysis was 
performed at 24 scans and at a resolution of 4 cm
-1
. Scanning was conducted in the mid-IR range 
from 400-4000 cm
-1
. Three measurements were carried out for each graft. 
 
2.2.3. SEM visualization 
The surface topography of the PET-Net was visualized using Scanning electron microscope SEM 
(Jeol JSM 7500 F, Japan) and compared to coated, unmodified PET. The grafts were mounted onto 
metal dishes using double-sided adhesive tape and conductive carbonic cement. A thin coat of 
platinum was prepared via a sputter coater (S150B, Edwards, England) under vacuum using an 
inert gas (argon) at 30 mA for 120 seconds before the grafts were observed. 
 
2.2.4. Biocompatibility study 
2.2.4.1. L929 cell adhesion and growth on PET-Net grafts 
The biocompatibility property of PET-Net was investigated using mouse fibroblast cell line L929 as 
a model. Slices of unmodified PET and PET-Net (1x1 cm
2
) were fixed onto sterile glass chips using 
inert, cell-nontoxic silicon glue and placed in a 12 well culture plate.  The L929 cells were seeded at 
a density of 1x10
5
 cells per well in 2 ml of DMEM medium supplemented with 10% FBS, 1mM L-
glutamine, penicillin (10.000 U/ml), streptomycin (10 µl/ml) and amphotericin B (25 μg/ml). The 
cultured grafts were incubated at 37°C and 8.5% CO2. The medium was changed daily for 9 
consecutive days.  
The number of adhered cells on PET-Net and unmodified PET was counted after 24h cell culturing. 
The medium was removed and the grafts were rinsed twice with sterile PBS at pH 7.4. The grafts 
were detached from glass chips and dipped into EBSS buffer solution without Ca
+2
 or Mg
+2
 for 5 
minutes at 25°C, followed by incubation in 1ml trypsin solution (5 mg/ml) at 37°C for 15 minutes 
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to isolate the adhered cells from the graft surface. The isolated cells were immediately counted 
using Neubauer chamber. The experiment was repeated in triplicate for each graft. 
To assess the growth of L929 cells on the prepared PET-Net, a graft sample was taken each day, 
rinsed twice with sterile PBS at pH 7.4 and immersed in 1% paraformaldehyde for 1h to fix the 
adhered cells. The grafts were dried under dust-free airflow and platinum sputtered as described 
above for SEM observation.  
 
2.2.5. Anti-adhesion efficiency of PET-Net grafts against bacterial strains 
The in-vitro anti-adhesion efficiency of PET-Net grafts was assessed against Gram- positive (S. 
epidermidis and S. aureus), and against Gram-negative E. coli pathogens.  
The bacteria were cultured on Col-S medium (Columbia Agar with 5% sheep blood, pH 7.3 ± 0.2, 
BD Biosciences, Germany) in an incubator (Heraeus BBD 6220,Germany) at 37°C, 5.5% CO2 and 
85% humidity for 24h. A fresh bacterial suspension from the last culture was prepared directly 
before use in sterile PBS at pH 7.4 containing 15 mM glucose. The optical density of the bacterial 
suspension was adjusted to a McFarland value of 1 (equivalent to 8x10
8 
CFU/ml) using a Densimat 
machine (bio Merieux, France). 
Slices of PET-Net and unmodified PET (0.5x0.5 cm
2
) were brought into contact with bacterial 
suspension and incubated for 24h as stated above. Afterwards, grafts were washed twice with 
sterile PBS at pH 7.4. To count the number of adhered bacteria, the grafts were incubated in 1ml 
trypsin solution (5 mg/ml) at 37°C under gentle stirring at 100 rpm/min for 20 minutes using HLC 
(HTMR 131, Germany) to detach the adhered bacteria from the surface. Ten microliters of the 
obtained bacterial suspension were spread onto Col-S medium in 90 mm petri dishes. The number 
of bacterial colonies was counted 24h after incubation. The experiment was repeated six times for 
each bacterial strain and the anti-adhesion efficiency was calculated using Equation (1): 
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Antiـadhesion	efficiency = A − BA  x		100%																																																														(1) 
Where, A is the number of grown colonies on the unmodified PET, and B is the number of grown 
colonies on the PET-Net. 
 
 2.2.6. Statistical analysis 
The data were expressed as means ± standard deviations of the representative experiments. 
Statistical comparisons were made by analysis of T-distribution and the difference was considered 
to be significant at p <0.05 for all evaluations. 
 
3. Result 
3.1. Surface characterization 
3.1.1. FTIR analysis  
Woven and Knitted forms of crimped PET grafts were surface oxidized by selective cleavage of the 
ester bond within the PET surface using piranha solution to produce negatively charged hydroxyl 
groups. The oxidized PET was confirmed by FTIR to detect the presence of the desirable groups on 
the surface. FTIR spectra of unmodified PET and oxidized PET are depicted in Figure 4. The spectra 
of unmodified PET showed a substantial strong intensity of carbonyl bonds (C=O) indicated by a 
stretching vibration at 1711 cm
-1
, and a medium intensity of aromatic (C=C), (=C-H) and (C-H) 
bonds detected by stretching vibrations at 1407, 870, 721 cm
-1
, respectively. At the same time, 
alkane (C-H) showed a stretching vibration at 1339 cm
-1
, and the ester bond (C-O) was indicated by 
the presence of three strong stretching vibration bands at 1239, 1091 and 1015 cm
-1
. The 
unmodified PET showed no peaks in the hydroxyl region (3000-3500 cm
-1
), whereas a distinctive 
band appeared in this region in the spectra of oxidized PET, indicating the presence of the desired 
negative hydroxyl groups. 
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Figure 4. FTIR spectra of oxidized (B) and unmodified PET (A) grafts. The selective absorption of light in the 
region of the hydroxyl group (3000-3500 cm
-1
) in oxidized PET is illustrated. 
 
3.1.2. SEM visualizations 
The surface modified and the unmodified PET grafts were dipped in the polymer solution to cast a 
film, followed by evaporation of the organic solvent under saturated humid conditions to obtain 
the appropriate coat characteristics. The topography of the obtained PET-Net was investigated 
using SEM and compared to the coated, unmodified PET (Fig. 5). SEM observations demonstrated 
formation of a porous architecture that displayed a variety of irregular pores resembling a 
network-structured film. Unlike the unmodified PET, the formed film on the oxidized PET was 
obviously not closely adhered to the surface and hence secured the flexibility of the graft fibers 
and its ability to tensile. In contrast, a porous film was closely associated with the unmodified PET 
which manifested a noteworthy reduction in fibers flexibility and tensile ability. 
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Figure 5. SEM micrographs visualize the coat architecture on woven PET. A closely adhered porous film was 
formed on the unmodified PET graft after dipping  in the polymer solution (A),  and  a network- structured 
film was formed on woven PET after switching the surface charge into negative by piranha solution (B).  
 
3.2. Biocompatibility study 
The biocompatibility property of the network-structured coat to host cells was evaluated using 
L929 cells as a model. The cells were cultured on PET-Net and on unmodified PET to assess the 
cellular adhesion and growth over several days. The cellular behavior revealed a slight decrease in 
the number of adhered L929 cells onto PET-Net. Importantly, the difference did not meet the 
statistical significance (P= 0.1) as illustrated in Figure 6.  
Figure 6. The number of L929 cells adhered on PET grafts after 24h cell culture. The adhered cells were 
counted (x10
4
 cell/cm
2
) after isolation from woven and knitted, PET-Net (black bars) and unmodified PET 
(white bars) using a Neubauer chamber. Results are given as mean ± standard deviation of three 
independent experiments. 
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The formed coat on woven and knitted PET-Net supported the cell adhesion and growth, and 
displayed compatible cellular behavior compared to unmodified PET at selected time intervals. 
The surfaces were similarly overgrown with a cellular monolayer after seven days (Fig. 7). 
 
Figure 7. SEM micrographs of L929 cells grown on PET-Net grafts. The multifunctional network- structured 
coat supported cell growth on woven (A) and knitted (B) PET-Net.  
 
3.3. Bacterial anti-adhesion efficiency of PET-Net  
The in-vitro anti-adhesion efficiency of PET-Net against three bacterial strains was investigated in 
comparison to unmodified PET. The grafts were incubated in S. epidermidis, S. aureus, or E. coli 
suspensions at pathogen concentrations of 8 x10
8 
CFU/ml for 24h. The attached bacteria were 
removed and cultured on agar blood medium. The CFUs numbers of the grown bacteria were 
counted thereafter for each strain as shown in Figure 8.  
Our results demonstrated that the number of Gram-positive S. epidermidis and S. aureus bacteria 
adhered on PET-Net recorded a significant reduction (p < 0.05) compared to unmodified PET (Fig. 
9. A and B). The adhesion of S. epidermidis previously isolated from a vein catheter decreased by 
2.6 and 2.3 fold and of S. aureus decreased by 2.3 and 2.4 fold for woven and knitted PET-Net, 
respectively. To similar extent, Gram-negative E. coli bacteria demonstrated significant (P = 0.003) 
reduction by 2.9 fold for woven PET-Net and 2.7 fold for knitted PET-Net (Fig. 9 C). Depending on 
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the number of adhered bacteria, the anti-adhesion efficiency of PET-Net was calculated using the 
equation (1). The anti-adhesion efficiency against S. aureus was 56.3 % and 58.9% for woven and 
knitted PET-Net, respectively. Interestingly, woven and knitted PET-Net showed a higher anti-
adhesion effectiveness (62.1 % and 56.9%, respectively) against S. epidermidis previously isolated 
from a vein catheter from a patient and thus especially relevant for the analysis. The anti-adhesion 
efficiency against Gram-negative E. coli was even more pronounced than that of the previously 
studied Gram-positive bacteria and showed 64.3 % and 63.1% for woven and knitted PET-Net, 
respectively.  
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Figure 8. Col-S bacterial culture of isolated S. epidermidis (A), S. aureus (B), and E. coli (C) bacteria 
harvested from PET-Net (right) and unmodified PET (left) grafts. The grafts were infected at a pathogen 
concentration of 8 x 10
8 
CFU/ml for 24h. 
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Figure 9. The number of bacteria adhered on woven and knitted unmodified PET and PET-Net grafts after 
24h incubation.  The number (x10
3
 CFU/ml) of adhered S. epidermidis (A), S. aureus (B) and E. coli (C) 
bacteria was counted after isolation from the corresponding woven and knitted grafts and culture on Col-S 
medium. Results are given as mean ± standard deviation of three independent experiments.  
 
4. Discussion 
Cardiovascular prostheses successfully restore the function of damaged vessels and cardiac valves 
[1-3]. Despite of the associated complications with PET grafts, the woven and knitted forms of 
crimped PET grafts are still the most effective employed biomaterials [1-3]. However, infections 
and the host response destruct the graft and damage the surrounding tissue which often 
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necessitates graft removal upon surgical operation [4,17]. Importantly, previous coating of the 
implanted grafts with biocompatible and anti-bacterial polymeric film may minimize the serious 
deteriorations post implantation. In this study, we took priority over coating the crimped PET 
grafts with a newly synthesized SD-PHA-b-MPEO diblock co-polymer (Fig. 2), utilizing its 
multifunctional advantages mainly the negative charge, hydrophobicity, and the bactericidal effect 
of the sulfadimethoxine (SD) moiety and pH responsiveness. The structure of the employed 
polymer was proven and characterized using nuclear magnetic resonance (NMR), infrared (IR) and 
UV spectroscopy before use [15]. 
The formed porous film displayed a local bactericidal effect and satisfied biocompatibility with the 
host cell while maintaining the tensile ability of the grafts. However, it was critical to conserve this 
flexibility and tensile ability of crimped PET after coating. Indeed, many factors influence the 
coating process of PET graft mostly; the chemical and physical properties of the used polymer, the 
topographic nature of filaments that form the graft surface and the coating conditions [18]. Thus, 
we intended to form the polymeric film by evaporating the water-immiscible polymer solvent 
under saturated humid atmosphere. Under these conditions, network architecture was 
preferentially produced [16]. A rate-determining step during our coating technique was that the 
PET surface initially had to be oxidized with piranha solution to acquire a negative charge 
comparable to that on the polymer surface (Fig. 4). As a result of the divergent hydrophobic 
properties of the polymer and the oxidized PET, the electrostatic repulsion of the negatively 
charged surfaces precluded the close adhesion of the polymer casted on the PET filaments (Fig. 5). 
This ensured continuous flexibility and mobility of the PET texture. Furthermore, the porous 
architecture attained suitable characteristics to PET surface in terms of cell adhesion and growth, 
which hold promise for sufficient coverage of the graft with host cell. This consideration is based 
on the fact that the adhesion and growth of the host cell on PET depend on surface 
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hydrophobicity, porosity, electronegativity, mechanical properties, and in particular the distance 
between individual filaments in the yarn [19,20]. Accordingly, the hydrophobic block of the 
polymer and the negative charge on its surface hampered the cell adhesion to a small non-
significant extent as shown by the decrease in the number of adhered L929 cells on PET-Net 
(Fig.6). In contrast, the formed network-structured coat provided a benefit to reduce the interval 
distance between the discrete filaments in the yarn. Additionally, the hydrophilic block of the 
polymer supported cell adhesion and growth and enabled the cells to bridge the filaments [19] 
(Fig. 3).  As a result, L929 cells readily overgrew the PET-Net after 7 days and a cellular monolayer 
was observed which was comparable to that observed on unmodified PET (Fig. 7).  
In general, bacterial adhesion and biofilm formation on the graft surface disturb host cell lining 
and stimulate the graft rejection [6]. Consequently, the anti-bacterial effect of the formed coat on 
PET-Net was investigated in-vitro against three different bacterial strains, namely S.epidermidis, 
S.aureus, and E.coli representing the most common Gram-positive and Gram-negative pathogens 
(Fig. 8).  
The calculated anti-adhesion efficiency of PET-Net against aforementioned bacteria indicated 
highly significant reduction on adhesion of all aforementioned strains compared to unmodified 
PET (P=0.003) (Fig. 9). Notably, we reinforced our results by using a violent pathogenic Gram-
positive S.epidermidis strain previously isolated from a patient`s vein catheter. Indeed, bacteria 
tend to adhere on and colonize preferably neutral and hydrophilic rather than hydrophobic 
surfaces [4]. This is avoided in the presence of polyhexylene and sulfadimethoxine groups in the 
formed multifunctional coat which switch the surface into hydrophobic and render the graft 
surface negatively charged. Additionally, the bacterial cell-repelling characteristics of polyethylene 
oxide guided synergistic antibacterial effect of the sulfadimethoxine group that make the modified 
PET graft even more unsuitable for bacterial adhesion and colonization. Furthermore, bacterial 
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adhesion could be influenced not only by electronegativity and hydrophobicity but also by surface 
porosity [21,22]. Therefore, the low porosity of the PET-Net makes it less favorable to bacterial 
adhesion. Interestingly, the formed multifunctional coat might offer additional advantages against 
bacterial biofilm formation due to pH responsiveness property of sulfadimethoxine group in range 
from 5.6 – 6 [15]. In particular, biofilm formation is initiated when bacteria attach to a surface and 
encase themselves in an acidic polysaccharide matrix [23]. In the presence of the pH responsive 
sulfadimethoxine group, the surface erosion of the film is accelerated at a slightly acidic pH and is 
accompanied by local release of sulfadimethoxine group in the surrounding area, providing an 
additional local anti-bacterial effect in the surrounding media.  
 
5. Conclusion 
We utilized a multifunctional network-structured film to preserve the flexibility and tensile ability 
of crimped PET grafts using amphiphilic SD-PHA-b-MPEO diblock copolymer. The produced coat 
offered a biocompatible contacting surface and held a bacterial anti-adhesion effect against both 
Gram positive and Gram negative bacteria. These data point out the utility of our new strategy to 
decrease the infection rate associated with cardiovascular grafts and increase graft patency.  
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Abstract 
Crimped polyethylene terephthalate PET is considered as the gold standard cardiovascular graft to 
restore the function of damaged vessels and heart valve. Graft-associated infections mostly the 
formation of bacterial biofilm entirely determines the short-term graft patency. We attempted to 
enzymatically inhibit the initial bacterial adhesion to PET grafts using lysozyme to eradicate 
predominantly Gram-positive bacteria. Woven and knitted forms of crimped PET grafts were 
surface-modified by Denier reduction to produce a functional carboxyl group. Lysozyme was 
covalently immobilized on the created carboxyl group by the end-point method. The surface-
modified grafts were characterized by Fourier-transform infrared spectroscopy and X-ray 
photoelectron spectroscopy. Most importantly, the bacterial anti-adhesion efficiency was 
empirically evidenced using Staphylococcus aureus, Staphylococcus epidermidis and Escherichia 
coli. Our figures of merit revealed lysozyme immobilization yield of 15.7 μg/cm
2
 as determined by 
the Bradford assay. The activity of immobilized lysozyme on woven and knitted PET manifested 
58.4% and 55.87% using Micrococcus lysodeikticus cells, respectively. Noteworthy, the adhesion of 
vein catheter-isolated S.epidermidis decreased by 6 and 8 fold and of S.aureus by 11 and 12 fold, 
while the Gram-negative E.coli showed only a decrease by 3 and 4 fold. The anti-adhesion 
efficiency was specific for bacterial cells and no significant effect was observed on adhesion and 
growth of L929 cells used as a model. In conclusion, immobilization of lysozyme onto PET grafts 
can modulate the initial adhesion of pathogenic bacteria and inhibit the graft-associated infection. 
 
Key words: Crimped cardiovascular PET; Lysozyme; Bacterial adhesion; Biofilm. 
 
 
 
41 
 
1. Introduction 
The utilization of polyethylene terephthalate, (PET) (Dacron
®
) in cardiovascular prosthesis has 
given rise to critical infections, mainly prosthetic valve endocarditis (PVE) and prosthetic vascular 
graft infection (PVGI) [1,2,3]. The development of infection starts primarily by bacterial adhesion 
onto graft surface via weak, reversible, physical forces followed by an adhesion cascade to secure 
successful attachment. The adhered bacteria proliferate and develop an irreversible attachment 
forming dense microbial communities called biofilm [4]. The formed biofilm exhibits a great ability 
to evade host defenses and to resist antimicrobial therapy and the human immune system [4,5]. 
Studies on pathogenic organisms responsible for PET graft infections have shown that 
Staphylococcus aureus is the infecting organism in ~70 % of cases, and Staphylococcus epidermidis 
encounters ~30% of the cases, resulting in prolonged hospitalization, graft failure, and patient 
death [6,7]. 
Different strategies have been developed to prevent bacterial colonization on cardiovascular 
prostheses after implantation. The most commonly used approaches are focused primarily on 
bonding of anti-infective agents onto-graft surface, mainly silver [8], quaternary ammonium [9] or 
antibiotics [10], in addition to systemic antibiotics as prophylaxis [11].  Alternatively, recent 
approaches to prevent bacterial adhesion and to eradicate the bacteria upon contact with the 
biomaterial surface were applied. For instance, strategies were used to block bacterial adhesion 
including; changing surface morphology [12], modifying surface features using either bio 
surfactants [13], or plasma [14]. In addition, soluble agents toxic to bacteria were used [15]. 
Nevertheless, previous strategies were limited by difficulties related to short active duration, high 
cost, and high host-cytotoxic potential even at low concentrations [16]. Furthermore, 
contradictory results were also reported by several studies concerning biofilm eradication [17,18]. 
Unlike previous studies, we aimed to inhibit the bacterial adhesion enzymatically using an enzyme 
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with lytic activity against bacteria. Accordingly, an antibacterial graft resisting broad-spectrum 
pathogens was developed. Lysozyme, or 1,4-β-N-acetylmuramidase, is an enzyme that displays 
lytic activity especially for Gram-positive bacteria such as S.aureus and S.epidermidis [19,20]. 
Lysozyme damages the bacterial cell wall by catalyzing the β(1-4) glucosidic bonds of murein 
resulting in an effective protection against bacterial adhesion and biofilm formation. This strategy 
provides many advantages compared to antibiotic or other agents including long-term duration, 
nontoxicity, local application without adverse effect on normal flora and inability of bacteria to 
develop a resistance against the enzyme. 
To the best of our knowledge, the covalent immobilization of lysozyme enzyme on woven and 
knitted forms of crimped PET cardiovascular grafts (Fig.1) is rarely addressed. In the current study, 
a hen egg white lysozyme was immobilized by the covalent end-point attachment technique to 
maintain its chemical stability and bioactivity after the immobilization process. 
 
Figure1. SEM micrographs of woven (A) and knitted (B) crimped PET grafts. The multifilament PET threads 
in woven grafts are fabricated in an over-and-under pattern, while in knitted grafts are looped. The crimped 
technique (shown in the picture) is utilized to increase the flexibility, distensibility, and kink-resistance of 
grafts. 
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The woven and knitted forms were surface-modified as schematically shown in Figure 2. Denier 
reduction was carried out to selectively cleave the ester linkage within the PET surface, resulting in 
a free carboxyl group that was used as an anchor site for covalent immobilization of lysozyme. The 
surface-modified PET was characterized by FTIR and XPS. The immobilization efficiency of the 
enzyme was determined by the Bradford assay and its activity compared to free enzyme using 
Micrococcus lysodeikticus cells was detected. The bacterial anti-adhesion efficiency of the enzyme-
immobilized grafts was studied against two Gram-positive (S.aureus, S.epidermidis) and one Gram-
negative pathogen (E.coli). The host cell behavior on the modified grafts was evaluated using 
mouse L929 fibroblasts as a model. 
 
Figure 2. Schematic illustration of covalent immobilization of lysozyme on the PET surface. The intrinsic 
ester linkage within the PET structure was cleaved by alkaline treatment to produce functional carboxyl 
group on the surface (PET-COOH). The PET-NH2 was obtained after grafting ethylendiamine on PET-COOH, 
while PET-Enz was obtained after immobilization of lysozyme by the end-point method. 
 
2. Materials and methods 
2.1. Materials 
Woven and knitted forms of crimped PET grafts (14mm internal diameter, 30 cm length and 12 
filaments per yarn bundle) were kindly provided by Vascutek GmbH, Germany. The bacterial 
strains Staphylococcus aureus (ATCC 29213), Staphylococcus epidermidis (isolated from a vein 
catheter of a patient), and Escherichia coli (ATCC 25922) were supplied from the Institute of 
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Medical Microbiology and Hospital hygiene, Marburg University, Germany. Lyophilized 
Micrococcus lysodeikticus (ATCC 4698) cells were purchased from Sigma Aldrich, Germany. 
Lyophilized powder lysozyme (EC 3.2.1.17) obtained from hen egg white (activity 
≥40,000 units/mg protein), N-hydroxysulfosuccinimide (Sulfo-NHS), 1-Ethyl-3-(3-dimethyl 
amidopropyl) carbodiimide hydrochloride (EDC), glutaraldehyde, and ethylendiamine were 
purchased from Sigma Aldrich, Germany. Sodium hydroxide was supplied by Carl Roth, Germany. 
Paraformaldehyde, Tris buffer, methylene blue, and Giemsa stain were purchased from Merck, 
Germany. 2-(N-morpholino) ethanesulfonic acid (MES) was acquired from Serva, Germany. The 
mouse L929 fibroblast cell line was from DSMZ, Braunschweig, Germany. Dulbecco’s modified 
Eagle’s medium (DMEM), Earle’s Balanced Salt Solution (EBSS), Fetal Bovine Serum (FBS), trypsin, 
streptomycin, penicillin, and amphotericin B were purchased from PAA Laboratories GmbH, 
Germany. L-glutamine was purchased from VWR, Germany. All other used chemicals were of 
analytical reagent grade. 
 
2.2. Methods 
2.2.1. Surface modification of crimped PET grafts 
In the present study, two different forms of crimped PET cardiovascular grafts woven and knitted 
were used for surface modification (Fig. 1). All steps in the subsequent experiments were 
performed for each form. To introduce a functional carboxyl group on the surface of the crimped 
PET grafts, modified Denier reduction was utilized as previously reported by Kissa [21], and 
schematically illustrated in Figure 2. Briefly, slices (2x2 cm
2
) from woven and knitted forms of 
crimped PET grafts were immersed in 20 ml of 50 % ethanol for 15 minutes in an ultrasonic water 
bath (Sonorex RK 100H, Bandelin, Germany) to clean the surface. Subsequently, the grafts were 
rinsed several times with distilled water under stirring and then oven dried at 55°C for 2h. The 
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cleaned grafts were dipped in 20 ml of 1% NaOH solution and incubated in a boiling water bath for 
1h. The modified grafts were rinsed with distilled water and oven dried for 2h at 55°C. The 
obtained grafts are abbreviated as PET-COOH. 
 
2.2.2.  Grafting of ethylendiamine onto PET-COOH 
Ethylendiamine was ligated to the previously produced carboxyl group using the adapted zero-
length cross linker reaction known as carbodiimide plus sulfo-NHS as previously reported [22]. 
Crimped PET-COOH were immersed in 15 ml of MES buffer (0.1 M, pH 5.5) and hydrated for 2h. 
The carboxyl group on the surface was activated by 0.1 M of EDC and 5 mM of Sulfo-NHS and 
incubated under gentle stirring at 50 rpm/min (IKA C-MHGHS7, Germany) at room temperature 
for 3h. A solution of 50 mM of ethylenediamine was slowly added to the activated PET-COOH. The 
conjugation between one terminal amino group of ethylendiamine and one carboxyl group on the 
surface of PET-COOH was carried out overnight at room temperature while stirring. The obtained 
grafts were rinsed with distilled water under sonication for 5 minutes and dried under dust-free 
airflow. The gained grafts are abbreviated as PET-NH2. 
 
2.2.3. Immobilization of lysozyme enzyme onto PET-NH2 
Lysozyme enzyme was covalently immobilized onto PET-NH2 using the homobifunctional cross-
linker glutaraldehyde as described elsewhere [23]. Briefly, PET-NH2 were immersed in 10 ml of 
sodium phosphate buffer (0.1 M, pH 6.8) containing 150 µl of 50 % glutaraldehyde and incubated 
at 4°C under gentle stirring at 50 rpm/min for 3h. Afterwards, the grafts were rinsed with distilled 
water under sonication for 5 minutes and dipped into 10ml of lysozyme solution (10 mg/ml) in 
phosphate buffered saline (PBS, 0.5 M, pH 7.4). The reaction was completed overnight at 4°C. The 
excess aldehydes and formed Schiff bases were reduced by adding 500 μl Tris buffer (0.2 M, pH 
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8.5) and incubation for 1h at 4°C. Finally, the grafts were washed with phosphate buffer and rinsed 
with distilled water under sonication for 5 minutes, and dried under dust-free airflow. The 
obtained grafts were stored at 4°C and are abbreviated as PET-Enz.  
 
2.2.4. Surface characterization after modification  
2.2.4.1. FTIR analysis 
FTIR Spectrometer (Alpha, Bruker, Germany) was utilized to detect the functional carboxyl group 
on the surface of modified PET-COOH compared to unmodified PET. The analysis was performed 
at 24 scans, and at a resolution of 4 cm
-1
. Scanning was conducted in the mid-IR range from 400-
4000 cm
-1
. Three different measurements were carried out for each graft. 
 
2.2.4.2. XPS analysis 
The chemical composition and survey spectra of modified and unmodified PET surfaces were 
investigated using XPS (PHI Versaprobe 5000, Physical Electronics, USA). The XPS spectra of PET-
Enz grafts were collected along with the native lysozyme and the unmodified PET as controls. XPS 
spectra were acquired at a chamber pressure in the range of 10
-8
 mbar using monochromatized Al 
1486.6 eV X-ray beams with an analytical spot size of 1400 µm x 200 µm. Two pass energies were 
chosen; 187.75 eV for survey scans and 23.5 eV for higher resolution scans. The binding energy 
scale was calibrated by shifting the C 1s aliphatic carbon peak to 284.8 eV. The XPS spectra were 
collected at the take-off angle 45° corresponding to a detection depth of about 4 nm for the 
relevant elements. 
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2.2.4.3. Determination of the concentration of immobilized enzyme 
The concentration of covalently immobilized lysozyme on PET-Enz grafts was determined using an 
adapted dye-interaction method based on the Bradford assay [24]. Briefly, dye reagent was 
prepared from Coomassie Brilliant Blue G-250 (10 mg) in 5 ml of 95% ethanol and 10ml of 85% 
(w/v) phosphoric acid. The resulting solution was diluted to a final volume of 100 ml. various 
known concentrations of native lysozyme in 100 μl aqueous solution were added to 5 ml of the 
previously prepared dye reagent, and agitated using a vortex (Reax 2000, Heidolph, Germany). The 
mixture was kept at room temperature for 10 minutes, and then centrifuged at 5000 rpm/min for 
15 minutes to separate the formed enzyme-dye complex. The absorbance of the supernatant that 
contains the free dye was measured within 30 minutes at 465 nm using a spectrophotometer 
(Thermo Fischer 1510. Finland). The linear inverse relationship between the absorbance at 465 nm 
caused by the residual dye and the concentration of enzyme in the aqueous solution was 
ascertained and used as a calibration curve to determine the amount of immobilized lysozyme 
enzyme.  
Accordingly, slices (1x1 cm
2
) of crimped PET- Enz grafts and PET-NH2, as control were immersed in 
5 ml dye reagent for 3h and gently mixed. The absorbance of dye solution above the graft was 
measured at 465 nm. The amount of immobilized enzyme was calculated using the previously 
constructed calibration curve. Since only a small amount of dye could be physically adsorbed onto 
dipped grafts, the removed grafts were rinsed again with 5ml of solution (5% ethanol, 10% 
phosphoric acid, 85% distilled water V/V/V) under sonication for 5 minutes and the absorbance of 
the dye in the washing solution was considered. The experiment was repeated in triplicate. 
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2.2.5. Evaluation of enzyme activity 
The activity of lysozyme was determined based on a turbidity assay using Micrococcus 
lysodeikticus cells as a substrate [25]. 
 
2.2.5.1. Activity of free enzyme  
A Micrococcus lysodeikticus cell suspension (0.02 % w/v; A450nm~ 0.7) was prepared in phosphate 
buffer (66 mM, pH 6.24). The lytic reaction was carried out in a quartz cuvette (3 ml) with 1cm 
light path at 25°C using a spectrophotometer. First, the substrate suspension was filled into the 
cuvette that was placed into a thermostatic measuring cell and incubated for 5 minutes to achieve 
temperature equilibration. Afterwards, 100 µl of freshly, pre-cooled lysozyme solution (400 U/ml 
in phosphate buffer) was added to the substrate cell suspension. The change in the absorption 
(ΔA450nm/minute) was recorded for 5 minutes. A blank assay without lysozyme was also performed 
to account for any autolytic degradation of the substrate. The experiment was carried out in 
triplicate, and one activity unit was defined as the absorption reduction of 0.001 per minute as 
illustrative in the equations: 
 
Enzyme activity (unit/mg) solid= 
∆A450nm/min test - ∆A450nm/min blank 
0.0010.1(mg used sample) 																																							1																											 
(unit/mg) Protein =
(unit/mg) solid
protein (%)
																																																																																																						 2 
 
2.2.5.2. Activity of immobilized enzyme  
The activity of immobilized lysozyme was estimated by addition of pre-cold PET-Enz graft into 2.5 
ml Micrococcus lysodeikticus cell suspension (0.02 % w/v) in phosphate buffer (66 mM, pH 6.24) at 
25°C. The ΔA450nm per minute of the substrate suspension was determined for 5 minutes. The 
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initial absorption of the lysozyme free-substrate suspension was also determined before the 
addition of PET-Enz. A blank assay was also conducted using pre-cold PET-NH2 to detect any 
changes in absorption due to non-enzymatic effects. The experiment was carried out in triplicate 
for each graft form and the enzyme activity was calculated as described above taking into account 
the concentration of enzyme per unit surface area. 
 
2.2.5.3. Anti-adhesion efficiency of PET-Enz grafts 
The anti-adhesion efficiency of immobilized lysozyme on crimped PET against bacteria was 
assessed in-vitro against S.aureus, S.epidermidis, and E.coli strains as Gram-positive and Gram-
negative microorganisms. 
The bacteria were cultured on Col-S medium (Columbia Agar supplemented with 5% sheep blood, 
pH 7.3±0.2, BD Biosciences, Germany) in a closed incubator (Heraeus BBD 6220, Germany) at 37°C, 
5.5% CO2 and 85% humidity for 24h. A fresh bacterial suspension was prepared directly before use 
in sterile PBS at pH 7.4 containing 15 mM of glucose. The optical density of the bacterial 
suspension was adjusted to a McFarland value of 1 (equivalent to 8x10
8  
CFU/ml) using a Densimat 
machine (bio Merieux, France). Slices of PET-Enz and PET-NH2 (0.5x0.5 cm
2
) were brought in 
contact with the bacterial suspension and incubated at 37°C, 5.5 % CO2 and 85 % humidity for 24h. 
Afterwards, grafts were washed twice with sterile PBS at pH 7.4. To count the adhered bacteria, 
the grafts were incubated in 1 ml trypsin solution (5 mg/ml) at 37°C under gentle stirring at 100 
rpm/min for 20 minutes using HLC (HTMR 131, Germany) to remove the adhered bacteria from 
the grafts surface, followed by spreading 10 μl of the resulting suspension on 90 mm petri dishes 
containing Col-S medium. The number of bacterial colonies was counted after 24h incubation at 
37°C, 5.5 % CO2 and 85 % humidity. The test was repeated six times for each bacterial strain and 
the anti-adhesion efficiency was calculated using equation (3): 
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Anti-adhesion efficiency = A-B
A
 ×100%                                                                          (3) 
A is the number of grown colonies on the control sample of the PET-NH2 and B is the number of 
grown colonies on the PET-Enz. 
 
2.2.5.4. Staining of bacteria 
Bacteria adhered to unmodified PET and PET-Enz grafts were also investigated via methylene blue 
staining. After removal from the bacterial suspension, grafts were washed with sterile PBS at pH 
7.4 and the bacteria were fixed in formalin solution (5%) for 5 minutes and rinsed with sterile 
water before a methylene blue drop was added. Thirty seconds later, grafts were directly washed 
with sterile water and dried at room temperature under a dust-free airflow. The stained bacteria 
were visualized at the same magnification for comparison purposes using an optical microscope 
(NLO-UV, Zeiss, Germany) equipped with a camera (Moticam 2000, USA). 
 
2.2.6. Biocompatibility study 
2.2.6.1. L929 cell adhesion and growth on PET-Enz grafts 
The biocompatibility property of PET-Enz grafts was investigated using the L929 cells as model. 
Slices of unmodified PET and PET-Enz grafts (1x1 cm
2
) were fixed onto sterile glass chips using 
inert cell-nontoxic silicon glue and set in a 12 well culture plate.  L929 cells were seeded at a 
density of 10
5 
cells per well in 2 ml of DMEM medium supplemented with 10 % gamma irradiated 
fetal bovine serum, 1 mM L-glutamine, penicillin (10.000 U/ml), streptomycin (10 µl/ml) and 
amphotericin B (25 μg/ml). The cultured grafts were incubated at 37°C and 8.5 % CO2. The 
medium was changed every day for 9 consecutive days. A graft sample was detached daily, rinsed 
twice with sterile PBS at pH 7.4 and immersed in 1% paraformaldehyde for 1h. Subsequently, the 
adhered cells after 24h cell culturing were stained with Giemsa stain (5%) for 10h followed by 
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color differentiation using diluted acetic acid (0.5%). The treated grafts were dried at room 
temperature under a dust-free airflow and viewed using an optical microscope (Stemi 2000-C, Carl 
Zeiss, Germany) equipped with Camera (Canon G10, Japan). For scanning electron microscopy 
(SEM) studies, the cultured grafts were rinsed twice with sterile PBS, and fixed with 1% 
paraformaldehyde for 1h. After washing with distilled water, dehydration was performed by slow 
water replacement using a series of ethanol solutions (50%, 70%, 80%, and 95%) for 90 minutes 
receiving final dehydration in absolute ethanol for 120 minutes. The samples were then dried 
using a critical point dryer (Bal-Tec, CDP 030, Germany) followed by gold sputtering via Sputter 
coater (S150, Edwards, England) under vacuum using an inert dusting gas (argon) at 25 mA for 120 
seconds, before they were visualized by SEM. 
 
2.2.6.2. Counting of L929 cells adhered to PET-Enz grafts 
The number of adhered cells on unmodified PET and PET-Enz grafts was counted 24h after cell 
culture. The medium was removed and the grafts were rinsed twice with sterile PBS at pH 7.4. The 
grafts were detached from the glass chips and dipped into EBSS buffer solution without Ca
+2
 or 
Mg
+2
 for 5minutes at 25°C, followed by incubation in 1 ml trypsin solution (5 mg/ml) at 37°C for 15 
minutes to remove the adhered cells from the graft surface. The isolated cells were immediately 
counted using a Neubauer chamber. The experiment was repeated in triplicate for each graft. 
 
2.2.7. Morphological analysis using SEM 
Scanning electron microscope (Hitachi S-510, Japan) was used to examine the adhesion and 
growth behavior of L929 cells on the surface of unmodified PET and PET-Enz grafts. The grafts 
were dried as described above and were mounted onto metal dishes using double-sided adhesive 
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tape and conductive carbonic cement. The grafts were gold sputtered as described above. All 
images were taken at 25 kv under the same magnification for comparison studies. 
 
2.2.8. Statistical analysis 
The data are expressed as means ± standard deviations of the representative experiments. 
Statistical comparisons were made by analysis of T-distribution and the difference was considered 
to be significant at a p < 0.05 for all evaluations. 
 
3. Results 
3.1. FTIR spectroscopy of surface functionalized PET-COOH graft 
Woven and knitted forms of crimped PET grafts were modified using the Denier reduction to 
introduce functional carboxyl groups on the surface. The created carboxyl group was activated by 
carbodiimide/sulfo-NHS and further used for conjugation of ethylendiamine as a spacer between 
the carboxyl group and lysozyme (Fig.2). 
FTIR was used to characterize PET-COOH after modification to detect the presence of the desirable 
functional group on the surface. FTIR spectra of unmodified PET and PET-COOH are depicted in 
Figure 3. The spectra of unmodified PET surface showed a substantial strong intensity of carbonyl 
bonds (C=O) indicated by the stretching vibration at 1711 cm
-1
, and a medium intensity of 
aromatic (C=C), (=C-H) and (C-H) bonds detected by stretching vibrations at 1407, 870, 721 cm
-1
, 
respectively. At the same time, alkane (C-H) showed a stretching vibration at 1339 cm
-1
, and the 
ester bond (C-O) demonstrated three strong stretching vibration bands at 1239, 1091 and 1015 
cm
-1
.  The unmodified PET surface showed no peaks in the hydroxyl region of the carboxyl group 
(3000-3500 cm
-1
), whereas a broad shoulder appeared in this region in the spectra of PET-COOH, 
indicating the presence of the desirable carboxyl group.   
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In addition, the preliminary FTIR spectrum of PET-NH2 was almost the same as that of the 
unmodified PET graft (data not shown). This is because the absorption frequencies of amide bonds 
based on (C=O) and (C-N) at (1650-1690 cm
-1
 and 1030-1220 cm
-1
, respectively) overlap with that 
of the ester groups in unmodified PET. However, the grafted ethylendiamine and lysozyme were 
confirmed using XPS. 
 
Figure 3. FTIR spectra of unmodified PET (A) and PET-COOH (B). The selective absorption of light in the 
region of the hydroxyl group derived from the carboxyl group (3000-3500 cm
-1
) in PET-COOH is illustrated. 
 
3.2. XPS surface analysis of PET-NH2 and PET-Enz grafts 
The chemical composition of native lysozyme, unmodified PET, PET-NH2 and PET-Enz grafts were 
calculated from XPS spectra and illustrated in Table 1. The results revealed a small amount of 
intrinsic silicon corresponding to the unmodified PET. A nitrogen component was observed on the 
surface only after grafting of ethylendiamine and markedly increased after enzyme immobilization 
based on the amino groups of the grafted molecules. Notably, chlorine and sulfur traces, which 
were present in native lysozyme, were only obviously observed on the surface of PET-Enz as a 
result of successful enzyme immobilization. 
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Furthermore, the XPS detail spectra for all samples outlined two main peaks corresponding to 
carbon and oxygen (data not shown), while additional peaks from nitrogen and sulfur were only 
found in native lysozyme and PET-Enz spectra (Fig.4). The N-1s signal at 399.6 eV and the most 
intense signal in S-2p at 163 eV were present in both samples and were contributed to nitrogen 
and sulfur species from the lysozyme. An additional minor S-2p peak can be found in the PET-Enz 
spectrum at 168 eV and may indicate the presence of (SO3)
-2
 species. 
Figure 4. XPS survey scans spectra for nitrogen (N-1s) and sulfur (S-2p) of unmodified PET (A), native 
lysozyme (B) and PET-Enz graft (C). Nitrogen and sulfur peaks solitary appeared in the spectra of native 
lysozyme and PET-Enz. 
 
    Table1. XPS Study of PET grafts after surface modification and enzyme immobilization 
 
PET Grafts 
  
Atomic Compositions (%) for Modified/Unmodified Grafts  
  Carbon 
(C-1s) 
Oxygen 
(O-1s) 
Silicon 
(Si-2p) 
Nitrogen 
(N-1s) 
Chlorine 
(Cl-2p) 
Sulfur 
(S-2p) 
Native lysozyme 65.2 14.6 - 19.1 0.4 0.7 
Unmodified PET 71.5 27.9 0.6 - - - 
PET-COOH
 * 
69.5 29.8 0.7 - - - 
PET-NH2 
† 
72.8 26.3 0.6 0.3 - - 
PET-Enz
‡ 
58.8  30.8  0.1 9.6  0.2  0.5  
*
PET-COOH was obtained after Denier reduction of PET. 
†
PET-NH2 was obtained by grafting ethylendiamine onto PET-COOH. 
‡
PET-Enz was obtained by immobilization of lysozyme onto PET-NH2. 
 
55 
 
3.3. Efficiency of enzyme immobilization onto PET-Enz grafts 
The concentration of covalently immobilized lysozyme onto PET surface was determined using the 
Bradford assay. The blank assay was carried out on PET-NH2, and the concentration of immobilized 
lysozyme was calculated from the prepared standard curve. The mean concentration of 
immobilized enzyme per unit surface area was appraised to be 15.7 μg/cm
2
 based on three 
independent experiments. 
 
3.4. Enzyme activity of free lysozyme versus immobilized lysozyme  
To assess the influence of the immobilization process on lysozyme performance, the enzyme 
activity was detected against Micrococcus lysodeikticus cells compared to free lysozyme. 
Immobilized lysozyme onto woven and knitted PET manifested 58.4 % and 55.87 % of free enzyme 
activity, respectively. Thus, despite a significant reduction as compared to free enzyme (P=0.007), 
the remaining activity of immobilized enzyme was still noteworthy and suggested that the desired 
effect on bacterial adhesion was possible. In addition, the enzyme activity was comparable on 
woven and knitted PET grafts and did not indicate any significant difference (P> 0.05) (Fig.5). 
 Figure 5.  Activity of lysozyme on woven (white bar), knitted (striated bar) PET-Enz grafts, and free enzyme 
(black bar). The lysozyme activity (unit/mg) was turbidimetric measured using Micrococcus lysodeikticus 
cells as substrate. Results are given as mean ± standard deviation of three independent experiments. 
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3.5. Anti-adhesion efficiency of PET-Enz against bacterial strains 
The in-vitro anti-adhesion efficiency of PET-Enz grafts against three bacterial strains was 
investigated. The grafts were incubated with S.aureus, S.epidermidis and E.coli suspensions at 
pathogen concentrations of 8x10
8 
CFU/ml for 24h. The attached bacteria were removed and 
counted by determining the number of CFUs after culture on agar blood medium, as shown in 
Figure 6.  
 
Figure 6. Col-S bacterial culture of isolated S.aureus (A) and E.coli (B) bacteria harvested from unmodified 
PET (left) and PET-Enz (right) grafts. The grafts were infected at pathogen concentrations of 8 x 10
8 
CFU/ml 
for 24h. 
 
Our results revealed that the number of Gram-positive S.aureus and S.epidermidis bacteria 
adhered on PET-Enz was reduced with a high statistical significance (p < 0.0001) as compared to 
unmodified PET (Fig.7 A and B). The adhesion of S.epidermidis isolated from a vein catheter 
decreased by 6 and 8 fold and of S.aureus by 11 and 12 fold. Gram-negative E.coli bacteria 
manifested lower, but still highly significant (P < 0.0001) reductions by 3 and 4 fold (Fig. 7C). The 
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number of adhered E.coli onto grafts was greater than that of Staphylococcus strains (P= 0.03). 
Furthermore, the number of bacteria adhered on all studied grafts demonstrated the pattern to 
be higher on woven than on knitted PET grafts, however this difference did not reach statistical 
significance(P > 0.05). 
Figure 7. The number of adhered bacteria on PET and PET-Enz grafts. The number (x10
3
 CFU/ml) of adhered 
bacteria was counted after isolation from the corresponding woven and knitted grafts. The isolated 
S.aureus (A), S.epidermidis (B) and E.coli (C) bacteria were cultured on Col-S medium. Results are given as 
mean ± standard deviation of three independent experiments. 
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Depending on the number of adhered bacteria, the anti-adhesion efficiency of PET-Enz grafts was 
calculated based on Equation 3. The anti-adhesion efficiencies of woven and knitted PET-Enz 
against S.aureus were 81.5 % and 80.8 % respectively, while against S.epidermidis were 84.5 % and 
87.8 %, respectively. The anti-adhesion efficiency against E.coli was 73.3 % and 74.1 % for woven 
and knitted PET-Enz, respectively. These results correlated well with the data acquired by optical 
microscope after methylene blue staining (Fig. 8).  
 
Figure 8. Micrographs of methylene blue stained, adhered S.aureus bacteria on woven PET (A), and on 
woven PET-Enz (B) grafts 24h after bacteria incubation. The PET-Enz demonstrated observable lower 
hospitability to bacteria than the unmodified PET. 
 
3.6. L929 cell adhesion and growth on modified PET-Enz grafts  
The biocompatibility property of PET-Enz grafts with host tissue was evaluated in-vitro using L929 
cells. Our results revealed no effect of immobilized enzyme on cell adhesion and growth. Both 
unmodified PET and PET-Enz grafts were first covered with a confluent cellular monolayer after 
seven days as observed by SEM (Fig.9). Furthermore, the cells count adhered to PET-Enz grafts 
recorded no significant difference compared with unmodified PET (p > 0.05) (Fig.10). These results 
correspond well with data acquired by optical microscope after Giemsa stain (Fig.11), and 
confirmed that the modifications in PET-Enz grafts did not provoke any variation in cellular 
behavior on the grafts surfaces.   
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Figure 9. SEM micrographs of L929 cells grown on woven (A1) and on knitted (B1) PET-Enz grafts after 7 
days. Cell growth on the corresponding unmodified woven (A) and knitted (B) PET demonstrated similar 
behavior. 
 
 
Figure 10. Number of adhered L929 cell on woven and knitted; PET-Enz (black bars) and unmodified PET 
(white bars). L929 cells were isolated and counted (x10
4
 cell/cm
2
) using a Neubauer chamber. Results are 
given as mean ± standard deviation of three independent experiments. 
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Figure 11. Micrographs of Giemsa stained, adhered L929 cells to woven (A1) and knitted (B1) PET-Enz grafts 
after 24h cell culturing. The cell adhesion on the corresponding unmodified; woven (A) and knitted (B) PET 
depicted similar profile. 
 
4. Discussion  
The impact and utility of PET grafts in vascular prostheses and heart valve sewing cuffs are limited 
due to the associated infections and biofilm formation [1,2,26]. The development of 
cardiovascular grafts resistant to biofilm formation is critical and is the major challenge to graft’s 
long-term patency. Herein, we modified PET grafts with the lysozyme to take advantage of its 
capacity to lyse β (1-4) glucosidic bonds in the bacterial cell wall, resulting in an effective 
protection against bacterial adhesion and biofilm formation [4,19,20]. 
The ligation of lysozyme on surfaces of woven and knitted forms of crimped PET cardiovascular 
grafts was initiated by Denier reduction to produce a functional carboxyl group on the PET surface 
(Fig. 2) [21]. Using FTIR, the presence of the desired functional group on PET-COOH was proved by 
a broad shoulder of hydroxyl from the carboxyl group (Fig. 3) [27]. Additionally, enrichment of the 
PET surface with carboxyl groups decreased the surface hydrophobicity and static water contact 
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angle, hence increasing in the wettability of PET-COOH was observed. A similar observation was 
previously reported and studied [21]. The generated functional group on PET-COOH was 
conjugated to one terminal amino group of ethylendiamine via an amide bond to form PET-NH2. 
The second amino group in ethylendiamine was further used as an anchor for enzyme 
immobilization to produce PET-Enz grafts. To avoid the reaction between the amino and carboxyl 
groups on the enzyme molecule, we used glutaraldehyde to activate the amino group of 
ethylendiamine on the surface of PET-NH2 by the end-over end method. This ensured that the 
interaction occurred only on the surface of the desired graft. 
Quantitative analysis of atomic concentrations obtained from XPS spectra of all grafts showed a 
marked reduction in carbon after Denier reduction (Table 1). This is attributed to the removal and 
loss of some molecules from the surface due to alkaline treatment [21]. Furthermore, PET-NH2 
contained nitrogen and had a low oxygen concentration, thus verifying the formation of amide 
bonds between the carboxyl group on the graft surface and the amino group in ethylendiamine 
molecule. The increase in nitrogen concentration on PET-Enz and the simultaneous appearance of 
chlorine and sulfur confirmed the successful lysozyme immobilization. This was confirmed by XPS 
spectra of native lysozyme and unmodified PET versus PET-Enz (Fig. 4). Corresponding to the XPS 
spectra of PET-Enz, the surface concentration of lysozyme as detected by the Bradford assay 
confirmed the successful immobilization of lysozyme on the surface. 
It was critical to prove the integrity of tertiary structure and active sites after immobilization of the 
enzyme. Therefore, we investigated the activity of immobilized enzyme on standard M. 
lysodeikticus cells [25]. Despite a minor reduction of the immobilized enzyme activity on woven 
and knitted PET grafts, we confirmed the maintained activity compared to free enzyme (Fig. 5).  
Accordingly, we found obvious anti-adhesion efficiency of the immobilized enzyme against three 
bacterial strains, namely S.aureus, S.epidermidis, and E.coli representing common Gram-positive 
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and Gram-negative pathogens. The results obtained using Equation 3 indicated a significant effect 
of PET-Enz grafts on adhesion of all bacterial strains compared to unmodified grafts. The decrease 
in the number of adhered bacteria on PET-Enz grafts (Fig.7) showed high statistical significance.  
Despite the detected activity of lysozyme, the results demonstrated a better activity of PET-Enz 
grafts against Gram-positive than Gram-negative bacteria. This attributed to that lysozyme, a 
glycoside hydrolase, cleaves the β (1-4) glucosidic bond between N-acetylmuramic acid and N-
acetyl-D-glucosamine residues in peptidoglycan of bacterial cell wall [19,20]. The targeted 
glucosidic β(1-4) bonds in a Gram-positive cell wall are uncovered and found in large quantities 
compared to the Gram-negative cell wall which contains an outer membrane [4,20]. Consequently, 
the enzyme on PET-Enz grafts can easily access these structures on Gram-positive bacteria, leading 
to pressure imbalance within the bacterial cell wall causing cell lysis and death (Fig.8) [4,19,20]. 
We notably reinforced our results by using a truly pathogenic Gram-positive S. Epidermidis 
bacterial strain isolated from a patient’s vein catheter. The PET-Enz significantly minimized the 
initial adhesion of the active pathogenic bacteria, a finding that promises eradication of 
subsequent biofilm formation. 
In contrast, the outer membrane of Gram-negative bacteria, the β (1- 4) glucosidic bonds are 
hidden under a layer of lipoproteins and only few exist in the pili on the cell surface. Accordingly, 
the enzyme activity is limited mainly to the pili and the burdened bacterial adhesion is without any 
effect on the wall structure [4,19,20]. In addition, peptidoglycan forms around 90 % of the dry 
weight of Gram-positive bacteria and only 10 % of Gram-negative strains [28]. Our PET-Enz grafts 
still retained activity against Gram-negative bacteria, may be explained by earlier findings stating 
that the irreversibly inactivated lysozyme showed antibacterial effects, suggesting that the 
antibacterial efficiency is not only attributable to its activity, but also to the alkaline nature of the 
enzyme [29]. 
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In our study, woven grafts were more hospitable to bacterial adhesion than knitted grafts. 
Bacterial adhesion could, in theory, be influenced by factors other than lysozyme including graft 
porosity, surface tension, and electronegativity [30]. According to our results, the lower porosity 
of the woven PET may make it more favorable to bacteria adhesion.  
To ensure complete healing after graft implantation, coating of the graft by the natural host cells is 
critical. This process can be disturbed by successful bacterial adhesion and biofilm formation on 
the grafts surface. Consequently, absence of biocompatibility at the graft tissue interface is crucial 
for initiation of the infection process [7]. Thus, the ability of PET-Enz grafts to support host cell 
adhesion and growth is decisive, which, apart from lysozyme, can be influenced by surface 
hydrophobicity, porosity, roughness, mechanical properties, and in particular the distance 
between individual filaments in the yarn.  All PET grafts in our study were readily overgrown by 
L929 cells used as a model to evaluate the cell hosting. No significant difference in the number of 
attached cells after enzyme immobilization was observed. A trend towards an increased number 
of adhered cells on PET-Enz graft compared to unmodified grafts showed no statistical significance 
(Fig.10 and 11). Altogether, these findings outline conformity of the modified grafts with the 
biocompatibility requirements for biomedical applications.  
 
5. Conclusion  
Immobilization of lysozyme enzyme on crimped PET cardiovascular grafts inhibited the initial 
adhesion of Gram-positive bacteria and to a lower extent in case of Gram-negative bacteria. The 
acceptable biocompatibility property of modified grafts highlights our strategy as a novel 
biocompatible, anti-bacterial platform for PET cardiovascular grafts to decrease the incidence of 
graft-associated infections. 
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Abstract 
Polyethylene terephthalate PET and expanded polytetrafluoroethylene ePTFE grafts are essentially 
employed to replace the damaged blood vessels and heart valves. However, the emerged critical 
complications after implantation prominently distract the grafts patency leading to prolonged 
hospitalization. We attempted to treat the main complications by local delivery of drugs from 
immobilized poly lactic-glycolic acid (PLGA) nanoparticles using Fluorescein isothiocyanate labeled 
dextran (FD) as hydrophilic model. The woven crimped PET and ePTFE were surface functionalized 
to produce amino group that was used as anchor site for immobilization of PLGA nanoparticles. 
The modified surface was characterized using electro kinetic analyzer, Fourier transform infrared 
spectroscopy, and scanning electron microscope. Importantly, the stability of immobilized 
nanoparticles on the grafts surfaces was investigated under continuous flow conditions, and the 
biocompatibility of the coated grafts was evaluated in-vitro using mouse L929 fibroblasts cell line 
as model. The results revealed a higher negative surface potential values (up to -41mV) at high 
pHs characteristic for amino functionalized PET. While the medium stretching at 2955 cm
-1
 
identified the amino group on the ePTFE surface. The FD-loaded PLGA nanoparticles prepared by 
double emulsion-solvent evaporation method displayed homogenous monolayer without 
aggregation on grafts surface and maintained a satisfactory stability over 24h under continuous 
flow. Additionally, the nano-immobilized grafts reported no significant effect on L929 cells 
adhesion and growth (P>0.05) compared to unmodified grafts. In conclusion, immobilization of 
nanoparticles on PET and ePTFE provide a stable and biocompatible model for local drug delivery 
proposed to treat the complications after implantation and enhance the grafts patency.  
 
Key words: PET; ePTFE; tissue engineering;  PLGA nanoparticles immobilization; hydrophilic 
model; biocompatibility.    
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1. Introduction 
Cardiovascular prosthesis has displayed highly successful applications and gained further a large of 
interest. Polyethylene terephthalate PET (Dacron
®
) and expanded polytetrafluoroethylene ePTFE 
(Teflon
®
) are preferably utilized to replace the damaged vessels and covering the sewing rings of 
heart valves and vascular stent (Fig.1).  
 
Figure 1. SEM micrographs of woven PET (A) and ePTFE (B) cardiovascular grafts. The filament in threads of 
woven PET are fabricated in an over-and-under pattern, while ePTFE is fabricated by heating, stretching, 
and extruding the polymer followed by cracking the developed grafts into non-woven porous tube. 
 
The high flexible mechanical feature and micro-porous wall structure of PET give advantages for 
substitution of large diameter vessels [1,2,3], whereas the relatively inert characteristics of ePTFE 
offer the priority for small and medium diameter vessels intended to restore the normal blood 
flow and cardiac output [1-3]. However, the utilization of PET and ePTFE cardiovascular grafts was 
reported to associate with critical complications mainly; thrombosis, inflammation, and infection 
leading to prolonged hospitalization, graft failure, and patient death [4,5]. This stated low patency 
is still in prerequisite to improvement despite the significant progress in development of PET and 
ePTFE grafts using tissue engineering, antithrombotic therapy, and endothelial cell seeding. An 
attractive approach is the encapsulation of suitable drugs in polymer nanoparticles from which 
they well be locally delivered to treat the common complications [6]. Nanoparticles, as drug 
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delivery system, provide many considerable benefits essentially the biocompatibility, drugs 
protection, local application, and avoidance of drug-side effect, while the controlled and sustained 
release of drug to the site of effect is one of the most advanced [7-10]. In present study, the two 
mostly employed cardiovascular grafts; woven crimped PET and ePTFE were coated using PLGA 
nanoparticles loaded with Fluorescein isothiocyanate labeled dextran (FD) as hydrophilic model 
for wide range of medical applications. The surfaces of PET and ePTFE were modified to produce 
functional amino group that was used as anchor site for immobilization of PLGA nanoparticles as 
schematically illustrated in Figure 2. The modified surface was characterized using electro kinetic 
analyzer, Fourier transform infrared spectroscopy (FTIR), and scanning electron microscope (SEM). 
Importantly, the stability of immobilized nanoparticles on the grafts surfaces was investigated 
under continuous flow conditions, and the host cell behavior on the coated grafts was evaluated 
in-vitro using mouse L929 fibroblasts cell line as model. 
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Figure 2. Schematic illustration of surface functionalization of; PET (A), ePTFE (B) and covalent 
immobilization of PLGA nanoparticles on the aminolated grafts (C). The intrinsic ester linkage within PET 
structure was cleavage by aminolysis reaction to produce functional amino group on the surface (PET-NH2). 
While the oxidation reaction was utilized to introduce functional hydroxyl groups on ePTFE surface using 
piranha solution to yield ePTFE-OH. Subsequently, ePTFE-NH2 was obtained by grafting 3-aminopropyl 
triethoxysilane on ePTFE-OH. The covalent immobilization of the nanoparticles was completed between the 
amino group on the aminolated graft and the carboxyl group on the PLGA nanoparticles using cross-linker 
glutaraldehyde. 
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2. Material and method 
2.1. Material 
Crimped woven polyethylene terephthalate PET (Dacron
®
,14 mm internal diameter, 30 cm length, 
12 filaments per yarn bundle), and expanded polytetrafluoroethylene ePTFE (Teflon
®
, 10 mm 
internal diameter, 20 cm length, 0,35 mm wall thickness) were kindly provided by Vascutek GmbH, 
Germany. Poly lactic-glycolic acid (PLGA RG503H) was bought from Boehringer Ingelheim, 
Germany. Fluorescein isothiocyanate labeled dextran (FD 10S), Ethylenediamine, glutaraldehyde, 
3-aminopropyl Triethoxysilane ≥ 98%, were purchased from Sigma Aldrich, Germany. 30 % H2O2 
and Tween
®
 80 were acquired from Carl Roth GmbH, Germany. Paraformaldehyde and Giemsa 
stain were bought from Merck, Germany. Mouse L929 fibroblasts cells line were obtained from 
DSMZ, Germany. Dulbecco's Modified Eagle's Medium (DMEM), Earle's Balanced Salt Solution 
(EBSS), Gamma Irradiated Fetal Bovine Serum (FBS), trypsin, streptomycin, penicillin, and 
amphotericin B were purchased from PAA Laboratories GmbH, Germany. L-glutamine was bought 
from VWR, Germany. All other used chemicals were of analytical reagent grade. 
 
2.2. Method 
2.2.1. Surface functionalization of PET and ePTFE 
In the present study, two different types of cardiovascular grafts, crimped woven polyethylene 
terephthalate (PET) and expanded polytetrafluoroethylene (ePTFE) were used for surface 
modification (Fig. 1). Each step in the subsequent experiments was done for each type.  
Initially, slices from PET and ePTFE grafts (2x2 cm
2
) were cleaned in 50 % ethanol under sonication 
(Sonorex RK 100H, Bandelin, Germany) for 15 minutes. Subsequently, the grafts were rinsed 
several times with distilled water under sonication and oven dried at 55°C for 2h before they were 
functionalized to produce reactive amino group on the surface (Fig. 2). The PET graft was surface 
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functionalized using modified aminolysis reaction according to the previously reported method 
[11]. The cleaned PET graft was dipped into 20 ml of 50 % ethylendiamine at 45°C for 15 minutes 
to selectively cleave the ester linkage within PET surface resulting in free amino group (Fig. 
2A).The aminolated PET graft was thoroughly rinsed with distilled water under sonication and 
oven dried at 55°C for 2h. The obtained graft is abbreviated as PET-NH2. Otherwise, the cleaned 
ePTFE graft was pre-oxidized using Piranha solution (30 % H2O2 and 96 % H2SO4 at 1:1 v/v) for 20 
minutes at room temperature to produce functional hydroxyl groups [12], the oxidized graft was 
rinsed thoroughly with distilled water and oven dried at 100°C for 1h. Afterwards, the dried graft 
was dipped into 20 ml chloroform solution of 3-aminopropyl triethoxysilane (20 µl/10 ml) for 2h. 
The graft was rinsed in chloroform and oven dried at 110°C for 2h to produce functional amino 
group on the surface (Fig. 2B). The obtained graft is abbreviated as ePTFE-NH2. 
 
2.2.2. Surface characterization 
2.2.2.1. Measurement of surface potential of PET-NH2  
Surface potential of PET-NH2 was measured using an electro kinetic analyzer (Sur PASS/Fa. A. 
PAAR, Austria) to detect the desired functional group on the surface in comparison to unmodified 
PET. The zeta potential/pH value function was measured in 1mM NaCl solution at pressure 300 
mbar and titration solutions: 0,1 M HCl and 0,1 M NaOH in a cylindrical measuring chamber 
particular for determination of the zeta potential of textile and fibers as shown in Figure 3A. Four 
potentials were measured at each pH value and two measurements per streaming direction of the 
electrolyte. The potential /pH function was expressed as the mean value of repetitive 
measurements.  
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2.2.2.2. FTIR Analysis  
An FTIR (Alpha, Bruker, Germany) was utilized to detect the functional groups on the surface of 
oxidized and aminolated ePTFE compared to unmodified ePTFE. The analysis was performed at 24 
scans and at resolution of 4 cm
-1
. Scanning was conducted in the mid-IR range from 400-4000 cm
-1
. 
Three measurements were carried out for each graft. 
 
2.2.3. PLGA nanoparticles synthesis  
PLGA nanoparticles (NPs) were prepared using adapted double emulsion-solvent evaporation 
method (W1/O/W2) as previously reported [13]. Briefly, 250 µl of  aqueous FD (25 mg/ml) was 
emulsified in 5 ml organic phase of PLGA solution (50 mg) in chloroform/acetone (3:2 v/v) using a 
high-speed homogenizer (Ultra-Turrax T25, IKA, Germany) operating at 10,000 rpm for 30 sec to 
yield the primary W1/O emulsion. The obtained primary W1/O emulsion was then directly dropped 
into 20 ml of continuous aqueous phase (W2) containing 0.1 % (w/v) Tween
®
80 using an electronic 
pump (Perfusor, Braun, Germany) at a constant flow rate of 1 ml/min and was continuously gently 
magnetic stirred at 300 rpm under a fume hood for 4h to allow the solvent evaporation and 
nanoparticles hardening. The obtained nanoparticles were collected by centrifugation at 15,000 
rpm for 10 minutes and washed twice with deionized water. After separation, the nanoparticles 
were re-suspended and were directly used for particles characterization and immobilization. For 
advanced study, the prepared nanoparticles were freeze-dried and stored at -20°C. Unloaded 
PLGA nanoparticles as control were also prepared without FD using the same procedure. 
 
2.2.4. Nanoparticles characterization  
2.2.4.1. Size and zeta potential measurements 
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The average size of PLGA nanoparticles, size distribution and the Zeta potential distribution were 
determined by MasterSizer (Zetasizer Nano-ZS, Malvern Instruments. UK) based on a laser light 
scattering technique. The samples was diluted in phosphate buffered saline (PBS, 0.5 M. pH 7.4) at  
1/100 ratio and vortex before the analysis was completed at; 25
◦
C, refractive index 1.59, medium 
refractive index 1.330, medium viscosity 0.88 mPas, dielectric constant 78.5, and at 17° scattering 
angle. The software DTS v 6.2 was used to calculate the particle mean diameter (Z-Ave), poly 
dispersity index (PDI) and average potential value (ζ potential). A Smoluchowsky constant F (Ka) of 
1.5 was used to achieve zeta potential value from electrophoretic mobility.  Each size and zeta 
measurement was performed with multiple runs, and all measurements were performed in 
triplicate directly after nanoparticle preparation. 
 
2.2.4.2.  Encapsulation efficiency 
The concentration of loaded FD in the synthesized NPs was determined after extraction as 
described previously [13]. Twenty milligram from the freeze-dried NPs were dissolved in 1 ml 
chloroform/acetone, followed by addition of 4 ml PBS at pH 7.4 and agitated using orbital shaker 
maintained at 37 ◦C for 15 h at 30 rpm. The concentration of extracted FD in the PBS buffer was 
determined by fluorescent spectrophotometer (LS 50B Luminescence Spectrometer, Perkin-Elmer, 
Germany) at excitation wavelength λe 494nm and emission λm510 nm. A calibration curve was 
arranged using standard solutions prepared by dissolving 20 mg of unloaded NPs in 1 ml 
chloroform/acetone mixed with increasing amounts of FD in 4 ml PBS at pH 7.4. The encapsulation 
efficiency was calculated from the mean value of three repeated experiments using Equation (1): 
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2.2.5. Immobilization of the NPs on PET-NH2 and ePTFE-NH2 
PLGA nanoparticles were covalently immobilized onto PET-NH2 and ePTFE-NH2 using 
homobifunctional cross-linker glutaraldehyde as described elsewhere [14] and schematically 
illustrated in Figure 2C. Briefly, the aminolated PET-NH2 and ePTFE-NH2 were immersed in 10 ml of 
sodium phosphate buffer (0.1 M, pH 6.8) containing 150 µl of 50 % glutaraldehyde and incubated 
at 4°C under gentle stirring at 50 rpm/min for 3h to activate the amino groups on the surface. 
Afterwards, the grafts were rinsed with distilled water under sonication for 5 minutes and dipped 
into 10 ml of NPs suspension in phosphate buffered saline (PBS, 0.5 M, pH 7.4). The reaction 
between the activated amino group on the graft surface and the carboxyl group on the NPs was 
completed overnight at 4°C. Finally, the grafts were rinsed with distilled water and dried under 
dust-free airflow. The obtained grafts were stored at 4°C and are abbreviated as PET-NPs and 
ePTFE-NPs, respectively. 
 
2.2.6. Stability of immobilized NPs under continuous flow condition 
The stability of immobilized NPs on graft surface was performed under continuous flow condition. 
Slices (0.5x0.5 cm
2
) of PET-NPs and ePTFE- NPs grafts were held tightly onto an inner side of 
silicone tube. The silicone tube was connected to a pump (Pump drive 5001, Heidolph, Germany) 
using silicone rubber pump tube (strength 1.6, Carl Roth, Germany). The prepared grafts attached-
silicone tube and saline solution were incubated in water bath at 37°C for 15 minutes to achieve 
temperature equilibration. The flow rate was operated using saline at 100 rpm/min for 24h. A 
graft sample was removed every 6h, rinsed with distilled water and dried followed by sputter 
coating with a thin film of platinum via Sputter coater (S150B, Edwards, England) under vacuum 
using an inert argon dusting gas at 30 mA for 120 seconds before they were observed by scanning 
electron microscope. 
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2.2.7. Biocompatibility study 
2.2.7.1. L929 cells adhesion and growth on PET-NPs and ePTFE-NPs 
The biocompatibility of PET-NPs and ePTFE-NPs with host cells was evaluated in vitro using mouse 
L929 fibroblast cell line as model. Slices (0.5x0.5 cm
2
) of PET-NPs, ePTFE-NPs and unmodified PET, 
ePTFE were fixed onto sterile glass chip using inert, cell-nontoxic silicon glue and placed in a 12 
well culture plate. L929 cells were seeded at a density of 1x10
5 
cells per well in 2 ml of DMEM 
medium, supplemented with 10 % FBS, 1 mM L-glutamine, penicillin (10.000 U/ml), streptomycin 
(10 µl/ml) and amphotericin B (25 μg/ml). The cultured grafts were incubated at 37°C and at 8.5 % 
CO2. The medium was changed daily for 9 consecutive days, and a graft sample was taken out 
daily, rinsed twice with PBS at pH 7.4 and immersed in 1% paraformaldehyde for 1h to fix the cells. 
The adhered cells after 24h culturing were stained by Giemsa stain (5 %) for 10h followed by color 
differentiation using 0.5 % acetic acid and dried at room temperature under dust free-airflow. The 
grafts were optically observed using microscope (Stemi 2000-C, Carl Zeiss, Germany) equipped 
with a camera (Canon G10, Japan). Furthermore, the fixed grown cells on grafts were observed 
using scanning electron microscopy after washing, drying, and preparation as previously 
described. 
 
2.2.7.2.  Counting of L929 cells adhered to PET-NPs and ePTFE-NPs 
The number of adhered cells onto PET-NPs, ePTFE-NPs was counted 24h after cell seeding in 
comparison to unmodified PET and ePTFE grafts. The medium was removed and the grafts were 
rinsed twice with sterile PBS at pH 7.4. The rinsed grafts were detached from the glass chips and 
dipped into EBSS buffer solution without Ca
+2
 or Mg
+2
 for 5 minutes at 25°C, followed by 
incubation in 1 ml trypsin solution (5 mg/ml) at 37°C for 15 minutes to remove the adhered cells 
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from the graft surface. The isolated cells were immediately counted using a Neubauer chamber. 
The experiment was repeated in triplicate for each graft. 
 
2.2.8. Scanning electron microscope  
A scanning electron microscope SEM (Jeol JSM 7500 F. Japan) was used to assess the stability of 
immobilized NPs after exposed to flow condition, and to observe the grown cells on PET-NPs, 
ePTFE-NPs grafts in comparison to unmodified grafts. The tested grafts were mounted onto metal 
dishes using double-sided adhesive tape and conductive carbonic cement. The platinum sputter 
coating was performed as previously described. All images were taken at 5 kV under the same 
magnification for comparison studies. 
 
2.2.9. Statistically analysis 
The data were expressed as means ± standard deviations of representative experiments. Statistical 
comparisons were made by analysis of T-distribution. The difference was considered to be 
significant at p < 0.05 for all statistical evaluations. 
 
3. Result 
3.1. Surface characterization 
FD-loaded PLGA nanoparticles as hydrophilic model were prepared for nano monolayer coating of 
crimped woven PET and expanded PTFE grafts. The grafts surfaces were modified to introduce 
functional amino groups used as anchor sites for covalent immobilization of the NPs (Fig.2). The 
PET was directly aminolyized by ethylendiamine, while ePTFE was pre-oxidized by Piranha solution 
to produce hydroxyl groups used for coupling of 3-aminopropyl triethoxysilane as a source of 
amino group on the surface. 
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The electro kinetic analyzer was used to detect the presence of the desirable reactive amino group 
on the functionalized PET-NH2 based on surface zeta potential. The potential /pH function of 
unmodified PET and PET-NH2 are depicted in Figure 3B. Negative surface potential was detected 
for all studied grafts. Notably, higher negative zeta potential values (up to -41mV) at high pHs was 
characteristic for PET-NH2 compared to irregular function with a drastic reduced potential 
detected on unmodified PET identified the presence of basic amino group on the surface.  
 
Figure 3. Measurement of the surface potential (A), and the zeta potential/pH value function of PET-NH2 
and unmodified PET (B). The PET sample was cut into slices and placed in a cylindrical measuring chamber. 
The measurement was carried out in 1mM NaCl solution at pressure 300 mbar and titration solutions: 0,1M 
HCl and 0,1M NaOH. The basic amino group on PET-NH2 demonstrated higher negative zeta potential values 
at high pHs compared to irregular function with a drastic reduced potential detected on unmodified PET. 
Results are given as mean value of four measurements at each pH value. 
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Otherwise, the oxidized ePTFE-OH and aminolated ePTFE-NH2 were characterized by FTIR to detect 
the presence of the functional groups on the surface. FTIR spectra of unmodified ePTFE, ePTFE-OH 
and ePTFE-NH2 are depicted in Figure 4. The spectra of unmodified ePTFE surface showed a 
substantial strong intensity of (C-F) bonds indicated by the stretching vibration at 1000-1400 cm
-1
. 
Additionally, a broad shoulder appeared at 3000-3500 cm
-1
 in the oxidized ePTFE-OH 
corresponding to hydroxyl group, and a medium intensity of (C=O) bonds detected by stretching 
vibrations at 1682 cm
-1
. The absence of hydroxyl stretching vibration in the ePTFE-NH2 
accompanied with medium stretching at 2955 cm
-1
 recognized the desired amino group on the 
surface.  
 
Figure 4. FTIR spectra of ePTFE-NH2 (C), and ePTFE-OH (B) compared to unmodified ePTFE (A) grafts. The 
selective absorption of light in the region of the hydroxyl group at 3000-3500 cm
-1
 and of carbonyl group at 
1682 cm
-1
 in ePTFE-OH is illustrated. While the medium stretching at 2955 cm
-1
 recognized the desired 
amino group on the surface of ePTFE-NH2. 
 
3.2. Nanoparticles characterization 
PLGA nanoparticles were obtained be double emulsion-solvent evaporation method and directly 
characterized after syntheses. The size and zeta potential characterization of FD-loaded PLGA NPs 
and unloaded are illustrated in table 1. The produced loaded particles displayed an increased 
mean size and polydispersity index comparing to the unloaded particles without effect on the 
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average potential value. Furthermore, the encapsulation efficiency of FD in the NPs prepared at 
1:10 FD/polymer rate manifested 41.3±3.8 %.    
Table 1.  Size and zeta potential characterization of unloaded and FD-loaded PLGA NPs 
 Particle size nm PDI* ζ potential 
Unloaded PLGA NPs 151.4±2.1 0.11±0.05 -23.3 ± 0.6 
FD-loaded PLGA NPs 178.2±2.9 0.17±0.08 -22.6 ± 0.8 
 
Data are shown as mean ± standard deviation from three experiments 
*PDI: polydispersity index 
 
 
3.3. NPs immobilization and stability evaluation under continuance flow condition 
The topographic features of the NPs-immobilized grafts were visualized using SEM compared to 
unmodified grafts. The SEM observation detailed a homogenous monolayer of NPs on PET-NPs 
and ePTFE-NPs grafts as shown in Figure 5. 
 
Figure 5. SEM micrographs of immobilized nanoparticles on PET-NPs and ePTFE-NPs (A1 and B1, 
respectively) compared to unmodified; PET (A) and ePTFE (B) grafts, and to the nano-immobilized grafts 
after continuous flow for 24h (A2 and B2, respectively). A homogenous monolayer of spherical, smooth 
surface nanoparticles on PET-NPs and ePTFE-NPs grafts was detected without aggregation on the surface. 
The identified nanoparticles displayed an observed stability under continuous flow over 24h. 
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The particles displayed a spherical shape with a smooth surface and no aggregation on the grafts 
surface was observed. Furthermore, the immobilized NPs on PET-NPs and ePTFE-NPs 
demonstrated satisfactory stability under appropriate human-mimic continuous flow conditions 
for 24h as both PET-NPs and ePTFE-NPs maintained an obviously monolayer coat of NPs. 
 
3.4. L929 cells adhesion and growth on PET-NPs and ePTFE-NPs 
The biocompatibility property of PET-NPs and ePTFE-NPs grafts with host tissue was evaluated in-
vitro using L929 cells. Our results revealed no effect of immobilized nanoparticles on cell adhesion 
and growth comparing to unmodified PET and ePTFE grafts. The primary optical micrographs of 
adhered cells stained with Giemsa 24h after cell seeding demonstrated normal cell behavior on 
PET-NPs and ePTFE-NPs (Fig.6).  
 
Figure 6. Micrographs of Giemsa stained, adhered L929 cells on PET-NPs (A) and ePTFE-NPs (B) grafts after 
24h cell culture. The nano-immobilized grafts obviously supported cell adhesion.  
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These results correspond well with data acquired by counting the adhered cells to NPs-
immobilized grafts which recorded no significant difference compared to unmodified grafts (p > 
0.05) (Fig.7). Furthermore, both unmodified and NPs -immobilized grafts were first overgrown 
with a confluent cellular monolayer after seven days of cell culturing, that confirmed the 
biocompatibility of PET-NPs and ePTFE-NPs which did not provoke any variation in cellular 
adhesion and growth of the host.  
 
Figure 7. Number of adhered L929 cell on PET-NPs and ePTFE-NPs (black bars) in comparison to unmodified 
PET and ePTFE (white bars). L929 cells were isolated and counted (x10
4
 cell/cm
2
) using a Neubauer 
chamber. Results are given as mean ± standard deviation of three independent experiments. 
 
4. Discussion:   
The patency of synthetic cardiovascular grafts made of PET and ePTFE is limited due to many 
complications after implantation [4,5]. Considering the reported success to the vascular 
prostheses and artificial heart valve, the used PET and ePTFE grafts have a potential for thrombus 
and bacterial infections that obviously restricted the long-term patency [5,6]. Wherefore, we 
aimed to support the grafts patency by local delivery of hydrophilic drugs using PLGA 
nanoparticles as carrier and FD as water soluble drug model. The NPs were covalently immobilized 
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to PET and ePTFE grafts after surface functionalization (Fig. 2). The functional amino group was 
directly produced on PET by aminolysis reaction using ethylendiamine to selectively cleavage of 
the ester bond resulting in PET-NH2 [11]. The produced amino group on PET-NH2 was proven 
based on the variation of surface potential realized by evaluating the pH-dependence 
(potential/pH functions) of the specific dissociable groups on the surface (Fig. 3). The aminolated 
graft demonstrated a negative potential over a wide pH range due to ionization of the surface 
amino group with an isoelectric point at around pH 7-8 conforming the successful amino 
functionalization [15]. 
While ePTFE was amino-functionalized by grafting 3-aminopropyl triethoxysilane to the previously 
produced hydroxyl groups using Piranha solution to yield ePTFE-NH2 [12]. The pre-oxidation 
process and the subsequent introducing of amino group on ePTFE was proven using FTIR 
corresponding to the broad shoulder in the range of hydroxyl group and the definite band of 
amino group [16] (Fig. 4). Afterwards, the produced amino groups on the surfaces were activated 
by glutaraldehyde and used further as anchor sites for covalent coupling to the carboxyl group in 
the PLGA nanoparticles. The nanoparticles were synthesized from biodegradable PLGA polymer for 
local, controlled release using FD as hydrophilic model, taking advantages of the high capacity of 
hydrophilic drugs by double emulsion-solvent evaporation method and the stability of obtained 
particles [13]. Additionally, for immobilization purpose, the intrinsic carboxyl groups in the PLGA 
made it our first choice for nanoparticles syntheses along with Tween
®
80 as surfactant at suitable 
concentration to stabilize the nano suspension. The surfactant adsorb at the particles surface 
between the superficially COOH groups leaving them free and available for coupling [17]. The 
marked increase in the size of the obtained FD-loaded NPs in comparison to unloaded NPs is 
attributed to expansion of polymeric matrix within FD encapsulation [13]. However, all particles 
seemed to possess the ideal surface charge suggesting that the surfactant and/or FD have no 
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masking effect on the superficial carboxylic groups [18]. However, the efficiency of NPs coating for 
cardiovascular grafts entails the stability during the massive blood flow to secure the local 
controlled release of encapsulated drug. Therefore, the stability of immobilized NPs was evaluated 
in-vitro under human-mimic conditions (Fig. 5). The surface visualization manifested permanence 
of monolayer coat on both PET-NPs and ePTFE-NPs after 24h substantial continuous flow 
providing an appropriate carrier for controlled drug delivery over the tested time. Nonetheless, 
the biocompatibility of the implanted grafts with natural host cells is critical and essential to 
ensure complete healing after graft implantation by comprehensive coverage with host cells. The 
ability of PET-NPs and ePTFE-NPs to support host cell adhesion and growth is decisive and 
displayed dependency on surface topography, hydrophobicity, and porosity [19,20]. Interestingly, 
the tested grafts were readily overgrown by L929 cells and shown no significant difference in the 
number of adhered cells on PET-NPs and ePTFE-NPs compared to unmodified grafts (Fig. 7). 
Furthermore, the hosting ability of the modified grafts was additionally confirmed by differential 
cell staining using Giemsa stain (Fig. 6). This highly emphasized the conformity of the nano-
immobilized grafts with the biocompatibility requirements for biomedical applications.  
 
5. Conclusion  
Immobilization of nanoparticles on crimped woven PET and expanded PTFE cardiovascular grafts 
provide a stable and biocompatible drug carrier that highlights our strategy as an effective local, 
controlled drug delivery model to treat the most common complications after implantation and 
hence enhance the grafts patency.  
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Abstract 
Short-term patency of polyethylene terephthalate (PET) cardiovascular grafts is determined mainly 
by the inherent thrombogenicity and improper endothelialization following grafts implantation. 
The aim of the present study was to immobilize heparin to develop thrombus resistant grafts. 
Additionally, collagen was co-immobilized to enhance the host cell compatibility. The synthetic 
woven and knitted forms of crimped PET grafts were surface modified by Denier reduction to 
produce functional carboxyl groups. The produced groups were used as anchor sites for covalent 
immobilization of heparin or co-immobilization of heparin/collagen by the end-point method. The 
modified surface was characterized using Fourier transform infrared spectroscopy and X-ray 
photoelectron spectroscopy. The biological activity of immobilized molecules was investigated in 
vitro using direct blood coagulation test, and platelets deposition under flow condition. 
Furthermore, the biocompatibility of modified grafts with host cells was assessed using L929 cell 
as model. All modified grafts showed significant resistance against fibrin and clot formation. The 
number of deposited platelets on heparin-immobilized woven and knitted grafts obviously 
decreased by 3 fold and 2.8 fold per unit surface area respectively, while the heparin/collagen co-
immobilized grafts showed only a decrease by 1.7 and 1.8 fold compared to unmodified PET. 
Heparin-immobilized grafts reported no significant effect on L929 cells adhesion and growth 
(P>0.05), conversely, collagen co-immobilization considerably increased cell adhesion almost ~ 1.3 
fold and 2 fold per unit surface area for woven and knitted grafts respectively. Our results 
emphasize that immobilization of heparin minimized the inherent thrombogenicity of the PET 
grafts. The simultaneous co-immobilization of collagen supported host cell adhesion and growth 
required for the grafts biocompatibility.  
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1. Introduction 
Polyethylene terephthalate (PET) Dacron
® 
grafts are promising alternatives for autologous grafts. 
The wide cardiovascular applications of PET grafts including; vascular prostheses [1,2], heart valve 
sewing cuffs [3,4], and surgical meshes [5] are associated with haemocompatibility problems [6,7]. 
One of the prominent shortcomings of PET is the substantial thrombogenic property that impaired 
ultimately the patency of the graft and hence, the patient`s life quality. After implantation, the 
blood coagulation cascade is mostly triggered at the graft-blood interface by the adsorption of 
plasma proteins on the graft surface followed by activation of platelets and complements in blood 
serum, and finally leads to formation of non-soluble fibrin and thrombosis [6,7]. However, the 
previous studies suggest that the sequences of protein deposition, fibrin formation, and platelets 
aggregation on graft surface showed dependency mainly on the surface properties [7].  
One potential strategy to reduce the thrombogenicity of prosthetic material is by immobilization 
of bioactive molecules to the graft surface. Recently, several studies have reported to the coating 
of heparin on surface as an effective method to create a thrombus-resistant graft [8-10]. Heparin, 
an anticoagulant non-branched mucopolysaccharide, prevents blood coagulation cascade by two 
ways; either directly by capture and inactivation of thrombin, or indirectly by stimulation of anti-
thrombin enzyme (AT III). Thrombin is an enzyme controls the conversion of soluble fibrinogen to 
precipitated fibrin fibers [11]. Additionally, a successful way to limit graft failure is to provide 
rapid, uniform, and complete coverage with an endothelial layer. Accordingly, cell growth on graft 
surface was enhanced using biomolecules such as insulin, transferrin, and peptides [12-14], 
whereas, tropoelastin, gelatin and collagen were used to stimulate cell adhesion and growth [15-
17]. To the best of our knowledge, the covalent immobilization of heparin on woven and knitted 
forms of crimped PET cardiovascular grafts (Fig.1) is rarely addressed. We aimed to improve the 
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blood compatibility properties to reduce thrombosis and platelets deposition on two different 
forms of crimped PET grafts by surface modification. 
 
Figure 1. SEM micrographs of unmodified woven (A) and knitted (B) forms of crimped PET grafts. The 
multifilament PET threads in woven grafts are fabricated in an over-and-under pattern, while PET threads in 
knitted grafts are looped. 
 
Denier reduction was employed to selectively cleave the ester linkage within PET surface resulting 
in free carboxyl group as schematically shown in Figure 2. Consequently, heparin was covalently 
immobilized to the resulting carboxyl group by the end-point attachment technique to maintain its 
chemical stability and bioactivity after immobilization process. To improve the endothelialization 
of cardiovascular PET grafts, the potential effect of collagen co-immobilization was evaluated. The 
surface modified PET was characterized by Fourier transform infrared spectroscopy (FTIR) and X-
ray photoelectron spectroscopy (XPS).The biocompatibility of modified crimped PET grafts was 
confirmed in-vitro by direct blood coagulation test and platelets deposition under continuous flow 
condition. In addition, mouse L929 fibroblast cell line was used as model to assess the host cell 
adhesion and growth on the modified grafts.  
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Figure 2. Schematic illustration of covalent immobilization of heparin (A), and co-immobilization of 
heparin/collagen (B) onto PET surface. The intrinsic ester linkage within the PET structure was cleaved by 
Denier reduction to produce functional carboxyl group on the surface (PET-COOH). Subsequently, the PET-
NH2 was obtained after grafting ethylenediamine on PET-COOH. The PET-Hep and PET-Hep-Col were 
obtained after immobilization of heparin or co-immobilization of heparin/collagen, respectively by the end 
point method. 
 
2. Materials and methods 
2.1. Materials 
Woven and knitted forms of crimped Dacron
®
; polyethylene terephthalate PET grafts (14 mm 
internal diameter, 30 cm length and 12 filaments per yarn bundle) were kindly provided by 
Vascutek GmbH, Germany. Heparin sodium salt; 196 USP (U/mg), 1-ethyl-3-(3-
dimethylamidopropyl) carbodiimide hydrochloride (EDC), N-hydroxysulfosuccinimide (Sulfo-NHS), 
glutaraldehyde, toluidine blue, and ethylenediamine were purchased from Sigma Aldrich, 
Germany. Sodium hydroxide was supplied by Carl Roth, Germany. Paraformaldehyde, Tris buffer, 
and Giemsa stain were bought from Merck, Germany. Water soluble collagen MW 80.000 and 2-N-
morpholinoethanesulfonic acid (MES) were acquired from Serva, Germany. Mouse L929 
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fibroblasts cells line were obtained from DSMZ, Braunschweig, Germany. Dulbecco’s Modified 
Eagle’s Medium (DMEM), Earle’s Balanced Salt Solution (EBSS), gamma irradiated Fetal Bovine 
Serum (FBS), trypsin, streptomycin, penicillin, and amphotericin B were purchased from PAA 
Laboratories GmbH, Germany. L-glutamine was bought from VWR, Germany. All other used 
chemicals were of analytical reagent grade. 
 
2.2.  Methods 
2.2.1. Surface modification of crimped PET grafts 
In the present study, two different forms of crimped PET cardiovascular grafts, woven and knitted 
as shown in Figure 1, were used for surface modification. All steps in the subsequent experiments 
were performed in triplicate for each form. Modified Denier reduction was used to introduce 
functional carboxyl groups on the surface of crimped PET grafts according to the method reported 
by Kissa [18] as schematically illustrated in Figure 2. Briefly, slices (2x2 cm
2
) from woven and 
knitted forms of crimped PET grafts were immersed in 20 ml of an 50 % ethanol solution for 
15minutes in an ultrasonic water bath (Sonorex RK 100H, Bandelin, Germany) to clean the surface. 
Subsequently, the grafts were rinsed several times with distilled water under stirring and then 
oven dried at 55°C for 2h. The cleaned grafts were dipped in 20 ml of 1% NaOH solution and 
incubated in a boiling water bath for 1h. The modified grafts were rinsed with distilled water and 
oven dried at 55°C for 2h. The obtained grafts are abbreviated as PET-COOH. 
 
2.2.2. Grafting of ethylenediamine onto PET-COOH  
Ethylenediamine was grafted onto previously produced carboxyl group using the adapted zero-
length cross linker reaction known as carbodiimide plus sulfo-NHS as previously reported [19]. 
Crimped PET-COOH were immersed in 15 ml of MES buffer (0.1 M, pH 5.5) and hydrated for about 
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2h. Carboxyl group on the surface was activated by adding 0.1 M of EDC and 5 mM of sulfo-NHS 
and incubated under gentle stirring at 100 rpm/min (IKA C-MHGHS7, Germany) at room 
temperature for 3h. A solution of 50 mM of ethylenediamine was slowly added to the activated 
PET-COOH. The conjugation between one terminal amino group of ethylenediamine and one 
activated carboxyl group on the surface of PET-COOH was completed overnight at room 
temperature while stirring. Afterwards, grafts were rinsed with distilled water under sonication for 
5 minutes and dried under dust free-airflow. The obtained grafts are abbreviated as PET-NH2. 
 
2.2.3. Immobilization of heparin onto PET-NH2 
Heparin was covalently immobilized onto PET-NH2 using homobifunctional cross-linker 
glutaraldehyde as described elsewhere [20]. Briefly, PET-NH2 (2x2 cm
2
) were immersed in 10 ml 
sodium phosphate buffer (0.1 M, pH 6.8) containing 150 µl of 50 % glutaraldehyde and incubated 
overnight at room temperature under gentle stirring at 100 rpm/min. Afterwards, grafts were 
rinsed with distilled water under sonication for 5 minutes and dipped into 10 ml of heparin 
solution (1 mg/ml) in sodium carbonate buffer (0.5 M, pH 9.5) at 4°C. The excess aldehydes and 
the formed Schiff bases were reduced by adding 500 μl Tris buffer (0.2 M, pH 8.5) and incubated 
at 4°C for 1h. Finally, the grafts were washed with sodium phosphate buffer and rinsed with 
distilled water under sonication for 5 minutes and dried at room temperature under dust free-
airflow. The obtained grafts are abbreviated as PET-Hep (Fig. 2A). 
 
2.2.4. Co-immobilization of heparin and collagen onto PET-NH2 
Collagen was co-immobilized with heparin onto PET-NH2 as previously described at concentration 
of 0.3 mg/ml and 0.7 mg/ml, respectively. The obtained grafts are abbreviated as PET-Hep-Col (Fig. 
2B). 
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2.2.5. Surface characterization after modification  
2.2.5.1. FTIR analysis 
An FTIR (Alpha, Bruker, Germany) was utilized to detect the functional carboxyl group on the 
surface of modified PET-COOH compared to unmodified PET. The analysis was performed at 24 
scans and at resolution of 4 cm
-1
. Scanning was conducted in the mid-IR range from 400-4000 cm
-1
. 
Three measurements were carried out for each graft. 
 
2.2.5.2. XPS analysis 
The chemical composition and survey spectra of modified and unmodified PET surfaces were 
investigated by XPS (PHI Versaprobe 5000, Physical Electronics). The XPS spectra of PET-Hep and 
PET-Hep-Col grafts were collected and compared with the corresponding native heparin, native 
collagen and unmodified PET. XPS spectra were acquired at a chamber pressure in range of 10
-8
 
mbar using a monochromatized Al 1486.6 eV X-ray beam with an analytical spot size of 1400 µm x 
200 µm. Two pass-energies were chosen; 187.75 eV for survey scans and 93.9 eV for higher 
resolution scans. The binding energy scale was calibrated by shifting the C1s aliphatic carbon peak 
to 284.8 eV. The XPS spectra were collected at the take-off angle 45° corresponding to a detection 
depth of about 4 nm for the relevant elements. 
 
2.2.5.3. Determination of immobilized heparin concentration on PET-Hep 
The concentration of covalently immobilized heparin on PET was determined using toluidine blue 
assay as previously reported [21]. Briefly, a dye reagent comprising from toluidine blue (5 mg) 
dissolved in 100 ml of 0.01 N hydrochloric acid containing 0.2 % NaCl was prepared. Two milliliters 
of various known concentrations of standard heparin in aqueous solution were added to 3 ml of 
the previously prepared dye reagent, and agitated using a vortex (Reax 2000, Heidolph, Germany). 
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The mixture was kept at room temperature for 10 minutes. Afterwards the formed toluidine blue-
heparin complex in the mixture was extracted into organic layer of n-Hexane (3 ml). After 
separation, the absorbance of aqueous layer, which contained the non-extracted dye was 
measured within 30 minutes at 631 nm using spectrophotometer (Thermo Fischer 1510, Finland). 
The linear inverse relationship between absorbance at 631 nm caused by residual dye and the 
concentration of heparin in the aqueous layer was ascertained and used as a calibration curve to 
determine the concentration of immobilized heparin on PET-Hep.  
Accordingly, slices (1x1 cm
2
) of PET-Hep were immersed into a solution composed of 3 ml 
toluidine blue and 2 ml distilled water. The mixture was shaken well and incubated at room 
temperature for 30 minutes. Afterwards, 3 ml of n-hexane was added and mixed to ensure 
uniformity in treatment. The aqueous layer was separated and measured at 631 nm. The 
concentration of immobilized heparin was then calculated using the previously constructed 
calibration curve. Since only small amount of dye could be physically adsorbed onto dipped grafts, 
the separated grafts were rinsed again with 5 ml of 0.01 N hydrochloric acid and 0.2 % NaCl under 
sonication for 5 minutes, and the absorbance of the dye in washing solution was considered. For 
comparison, parallel experiment for PET-NH2 was conducted. 
 
2.2.6. In-vitro biocompatibility study  
2.2.6.1. Platelets deposition on PET-Hep and PET-Hep-Col under continuous flow condition  
Fresh whole blood from healthy human donator taking no therapy for at least 4 weeks was 
collected into anticoagulant sodium citrate at blood/citrate ratio 9:1 v/v. Platelets-Rich Plasma 
(PRP) was prepared by centrifuging the blood at 800 rpm for 13 minutes at 24°C. The PRP was 
separated and the platelets count was adjusted to 200 000 platelets /µl using saline. 
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Platelets deposition study was performed under continuous flow condition. Slices (0.5x0.5 cm
2
) of 
unmodified PET, PET-Hep and PET-Hep-Col were held tightly onto an inner side of silicone tube. 
The silicone tube was connected to a pump (Pump drive 5001, Heidolph, Germany) using silicone 
rubber pump tube (strength 1.6, Carl Roth, Germany). The prepared platelets suspension and 
grafts attached-silicone tube were incubated in water bath at 37°C for 15 minutes to achieve 
temperature equilibration. The flow rate was then adjusted to 100 rpm/min. Flow was primed 
with saline at 37°C for 2 minutes then displaced by platelets suspension. After 30 minutes, the 
grafts were rinsed twice with saline and immersed in PBS containing 1% paraformaldehyde at pH 
7.4 for 1h to fix the deposited platelets. After washing with distilled water, dehydration was 
performed by slow water replacement using series of ethanol solutions (50%, 70%, 80%, and 95%) 
for 90 minutes receiving final dehydration in absolute ethanol for 120 minutes. The grafts were 
then dried using a critical point dryer (Bal-Tec, CDP 030,  Germany) followed by gold sputtering via 
Sputter coater (S150, Edwards, England) under vacuum using an inert argon dusting gas at 25 mA 
for 120 seconds before they were observed by scanning electron microscope. Silicone rubber 
tubes and pumping may lead to morphological changes to platelets due to flow rate. Hence, 
during the experiment, samples of platelets suspension were collected at 10 minutes intervals and 
the platelets aggregation or damage was investigated. However, no changes in platelets were 
observed during 30 minutes continuous flow study.  
 
2.2.6.2. Counting of deposited Platelets on PET-Hep and PET-Hep-Col 
The last procedure was repeated to count the deposited platelets on the examined grafts. After 30 
minutes continuous flow, platelets deposited PET grafts were taken out, rinsed with saline and 
dipped in EBSS buffer solution without Ca
+2
or Mg
+2
 at room temperature for 5 minutes. To remove 
the deposited platelets from the surface, grafts were incubated in 1ml trypsin solution (5 mg/ml) 
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at 37°C under gentle stirring 100 rpm/min for 15 minutes. The number of isolated platelets were 
immediately counted using Neubauer chamber. 
  
2.2.6.3. Blood coagulation test on PET-Hep and PET-Hep-Col 
Slices (1x1 cm
2
) of unmodified PET, PET-Hep and PET-Hep-Col were wetted in saline and dipped 
into whole blood in water bath at 37°C for 10 minutes under gentle manual shaking. Afterwards, 
grafts were washed with saline and fixed with 1% paraformaldehyde at pH 7.4 for 1h. The grafts 
were rinsed with distilled water and dried as previously described before scanning electron 
microscopic observation. 
  
2.2.6.4. L929 cells adhesion and growth on PET-Hep and PET-Hep-Col 
L929 cell line was used as model to evaluate the biocompatibility of the PET-Hep and PET-Hep-Col 
with host tissue. Slices (0.5x0.5 cm
2
) of unmodified PET, PET-Hep, and PET-Hep-Col were fixed 
onto sterile glass chip using inert, cell-nontoxic silicon glue and placed in a 12 well culture plate. 
L929 cells were seeded at a density of 1x10
5 
cells per well in 2 ml of DMEM medium, 
supplemented with 10 % FBS, 1 mM L-glutamine, penicillin (10.000 U/ml), streptomycin (10 µl/ml) 
and amphotericin B (25 μg/ml). The cultured grafts were incubated at 37°C and at 8.5 % CO2. The 
medium was changed daily for 9 consecutive days, and a graft sample was taken out daily, rinsed 
twice with PBS at pH 7.4 and immersed in 1% paraformaldehyde for 1h to fix the adhered cells. 
Afterwards, the adhered cells after 24h culturing were stained by Giemsa stain (5 %) for 10h 
followed by color differentiation using 0.5 % acetic acid and dried at room temperature under dust 
free-airflow. The grafts were optically observed using microscope (Stemi 2000-C, Carl Zeiss, 
Germany) equipped with a camera (Canon G10, Japan). For scanning electron microscopy studies, 
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the cultured grafts were rinsed twice with PBS at pH 7.4 and fixed with 1% paraformaldehyde for 
1h. The washing, drying, and sputter coating were conducted as previously described. 
 
2.2.6.5. Counting of adhered L929 cells to PET-Hep and PET-Hep-Col 
The number of adhered cells onto unmodified PET, PET-Hep, and PET-Hep-Col was performed 24h 
after cell culture. The medium was removed and the grafts were rinsed twice with sterile PBS at 
pH 7.4. The grafts were detached from glass chip and the adhered cells were removed using 
trypsin as described above. The number of isolated cells was immediately counted using Neubauer 
chamber.  
 
2.2.7. Morphological observation using SEM 
Scanning electron microscope SEM (Hitachi S-510, Japan) was used to observe the deposited 
platelets, blood clot, and L929 cells adherence and growth on unmodified PET, PET-Hep and PET-
Hep-Col. The grafts were dehydrated using series of ethanol solutions, and dried by a critical point 
dryer as described above. Next, the grafts were mounted onto metal dish using double-sided 
adhesive tape and conductive carbonic cement. Gold sputter was conducted as described above. 
All images were taken at 25 kV under the same magnification for comparison study.  
 
2.2.8. Statistically analysis 
The data are expressed as means ± standard deviations of representative experiments. Statistical 
comparisons were made by analysis of T-distribution. The difference was considered to be 
significant at p < 0.05 for all statistical evaluations. 
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3. Results 
3.1. FTIR surface characterization of functionalized PET-COOH  
Woven and knitted forms of crimped PET grafts were surface modified using Denier reduction to 
produce functional carboxyl groups on their surfaces. The produced PET-COOH was activated 
using carbodiimide and sulfo-NHS and further used for grafting ethylendiamine as a spacer to yield 
PET-NH2. Finally, PET-NH2 was used for heparin immobilization or heparin/collagen co-
immobilization to produce PET-Hep or PET-Hep-Col, respectively (Fig. 2).  
FTIR was used to characterize PET-COOH after modification to detect the presence of the desirable 
functional group on the surface. FTIR spectra of unmodified PET and PET-COOH are depicted in 
Figure 3.  
Figure 3. FTIR spectra of unmodified PET and PET-COOH. The selective absorption of light in the region of 
the hydroxyl group derived from the carboxyl group (3000-3500 cm
-1
) in PET-COOH is illustrated. 
 
The spectra of unmodified PET surface showed a substantial strong intensity of carbonyl bonds 
(C=O) indicated by the stretching vibration at 1711 cm
-1
, and a medium intensity of aromatic 
(C=C), (=C-H) and (C-H) bonds detected by stretching vibrations at 1407, 870, 721 cm
-1
, 
respectively. At the same time, alkane (C-H) showed a stretching vibration at 1339 cm
-1
, and the 
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ester bond (C-O) was indicated by the presence of three strong stretching vibration bands at 1239, 
1091 and 1015 cm
-1
.  The unmodified PET surface showed no peaks in the hydroxyl region of the 
carboxyl group (3000-3500 cm
-1
), whereas a broad shoulder appeared in this region in the spectra 
of PET-COOH, indicating the presence of the desirable carboxyl group.   
In addition, after grafting of ethylendiamine, the preliminary FTIR spectrum of PET-NH2 was almost 
the same as that of the unmodified PET graft (data not shown). This is because the absorption 
frequencies of amide bonds based on (C=O) and (C-N) at (1650-1690 cm
-1
 and 1030-1220 cm
-1
, 
respectively) overlap with that of the ester groups in unmodified PET itself. However, the grafted 
ethylendiamine, heparin, and collagen on the surface were confirmed using XPS. 
 
3.2. XPS surface analysis of PET-NH2, PET-Hep and PET-Hep-Col  
The chemical compositions of native heparin, native collagen, unmodified PET, PET-NH2, PET-Hep, 
and PET-Hep-Col were calculated from the XPS spectra as illustrated in Table 1. The results 
revealed a small amount of intrinsic silicon corresponding to the unmodified PET. The carbon 
component of the unmodified PET was decreased after alkaline treatment. In addition, nitrogen 
component was observed on the surface only after grafting of ethylendiamine and obviously 
increased in PET-Hep and PET-Hep-Col based on the amino groups of immobilized molecules. 
Notably, sulfur and sodium traces which were present in native heparin and native collagen were 
observed only on the surface of PET-Hep and PET-Hep-Col as a result of successful immobilization 
of heparin, and co-immobilization of heparin and collagen. Furthermore, the XPS detail spectra for 
all samples outlined two main peaks corresponding to carbon C-1s at 284.8 eV and oxygen O-1s at 
532 eV. Two additional peaks from nitrogen N-1s at 399.6 eV and sodium Na-1s at 1071 eV were 
found in native heparin and collagen, and obviously observed on PET-Hep, whereas their 
corresponding elements in PET-Hep-Col spectra were more intense as shown in Figure 4. 
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Moreover, the peak of sulfur S-2p around 168 eV coincided with a satellite of strong silicon Si2p 
line at 153.3 eV of PET itself 
 
Table1. XPS Study of PET after surface modification and heparin/collagen immobilization 
a
 PET-COOH was obtained after Denier reduction of PET. 
b 
PET-NH2 was obtained by grafting of ethylendiamine onto PET-COOH. 
c
 PET-Hep was obtained by immobilization of heparin onto PET-NH2. 
d
 PET-Hep-Col was obtained by co-immobilization of heparin and collagen onto PET-NH2 
 
 
 
Figure 4. XPS survey scan spectra of unmodified PET graft (A), PET-Hep (B), and PET-Hep-Col (C). The XPS 
spectra of the native heparin (D) and collagen (E) are shown. Nitrogen (N 1s) and sodium (Na 1s) peaks 
were solitary appeared in the spectra of PET-Hep and PET-Hep-Col in accordance with the corresponding 
native compounds. 
 
 
 
PET Grafts 
  
Atomic Compositions (%) for Modified/Unmodified Grafts  
  Carbon 
(C-1s) 
Oxygen 
(O-1s) 
Silicon 
(Si-2p) 
Nitrogen 
(N-1s) 
Sodium 
(Na-1s) 
Sulfur 
(S-2p) 
Native heparin 38.9 45.3 - 2.8 7.9 5.0 
Native collagen 81.4 13.1 - 5.1 0.2 < 0.1 
Unmodified PET 71.5 27.6 1.3 - - - 
PET-COOH
 a 
69.5 29.8 0.7 - - - 
PET-NH2 
b 
72.8 26.3 0.6 0.3 - - 
PET-Hep
c 
69.5  28.5  0.6 1.1  0.2  < 0.1  
PET-Hep-Col
d
 70.4 24.6 0.7 3.6 0.6 < 0.1 
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3.3. Efficiency of heparin immobilization on PET-Hep 
The concentration of covalently immobilized heparin on PET surface was determined using 
toluidine blue assay. The blank assay was carried out using PET-NH2 and the concentration of 
immobilized heparin was calculated from the prepared standard curve. However, the mean 
concentration of immobilized heparin per unit surface area of woven and knitted PET was 
appraised to be 1.31 μg/cm
2
 based on three independent experiments. 
 
3.4. In-vitro biocompatibility of PET-Hep and PET-Hep-Col grafts 
3.4.1. Platelets deposition 
The platelets deposition on PET-Hep and PET-Hep-Col was assessed using appropriate continuous 
flow condition and the number of adhered platelets was calculated per unite surface area of the 
studied graft. The SEM micrographs in Figure 5 demonstrated the platelets deposition on 
unmodified woven and knitted PET (A, B), PET-Hep (A1, B1), and PET-Hep-Col (A2, B2).  
Figure 5. SEM micrographs of platelets deposited on PET grafts under flow condition. The platelets on 
unmodified woven (A) and knitted (B) PET grafts showed massive aggregation and demonstrated 
pseudopodia. The woven (A1) and Knitted (B1) PET-Hep, and woven (A2) and knitted (B2) PET-Hep-Col 
grafts showed obvious reduction in platelets deposition.  
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The platelets deposition was significantly reduced on PET-Hep and PET-Hep-Col. Specifically, the 
platelets deposited on woven and knitted PET-Hep and PET-Hep-Col exhibited fewest pseudopodia 
and aggregation compared to unmodified PET. From the statistical point of view, the number of 
deposited platelets on both woven and knitted PET-Hep decreased by 3 and 2.8 fold compared to 
unmodified PET at P=0.001. Lower platelets were deposited on PET-Hep-Col showed only 1.7 and 
1.8 fold decrease in number per unite surface compared to unmodified PET at P = 0.01 (Fig. 6). 
 
Figure 6. The number of platelets deposited on PET grafts under flow condition. The platelets number (x10
3
 
platelet/cm
2
) was counted after isolation from woven and knitted forms of; unmodified PET (white bars), 
PET-Hep (black bars), and PET-Hep-Col (striped bars). Results are given as mean ± standard deviation of 
three independent experiments. 
 
3.4.2. Blood coagulation test  
Direct blood coagulation test was conducted on PET-Hep, PET-Hep-Col and unmodified PET in 
human-mimic conditions. Figure 7 shows SEM micrographs of formed clot and fibrin fibers on 
unmodified crimped woven PET (A), PET-Hep (B) and PET-Hep-Col (C). Similar results were 
detected for knitted grafts (data not shown).  A wide clot was detected on unmodified PET 
107 
 
demonstrating intensive fibrin fibers on broad area of the graft surface, whereas, PET-Hep and 
PET-Hep-Col displayed a remarkable anti coagulation effect and only few fibrin fibers could be 
detected as shown in the corresponding magnified SEM micrographs (Fig. 7). Nevertheless, our 
results revealed that PET-Hep-Col supported more formation of fibrin fibers than PET-Hep. 
 
Figure 7. SEM micrographs of blood clot formed on woven PET grafts. Clot formed on unmodified PET (A), 
PET-Hep (B), and PET-Hep-Col (C) are shown. The magnified micrographs of unmodified PET (A1) showed 
well-formed enormous clots accompanied by intensive fibrin fibers, while PET-Hep (B1) and PET-Hep-Col 
(C1) illustrated clot resistance surface.  
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3.4.3. L929 cells adhesion and growth on PET-Hep and PET-Hep-Col grafts 
The biocompatibility of modified PET grafts with host tissue was tested in-vitro using L929 cells as 
model. The cell adhesion and growth on woven and knitted PET-Hep and PET-Hep-Col were 
investigated and compared to unmodified PET. Our primary SEM micrographs confirmed the cell 
adhesion and growth on the investigated grafts (Fig. 8). PET-Hep demonstrated no significant 
effect on the cell behavior. Both unmodified PET and PET-Hep were first overgrown with confluent 
cellular monolayer after seven days. Furthermore, the potential effect of collagen on PET-Hep-Col 
to support cell adhesion and growth was obviously observed within 5 days compared to 
unmodified PET and PET-Hep.  
 
Figure 8. SEM micrographs of grown L929 cells on PET grafts. Confluent cell monolayers on unmodified 
woven (A) and knitted (B) PET, and on woven (A1) and knitted (B1) PET-Hep grafts were observed first after 
7 days, while on woven (A2) and knitted (B2) PET-Hep-Col were early observed after 5 days.  
 
An increase in the number of adhered cells on woven and knitted PET-Hep was barely observed 
compared to the corresponding unmodified PET with no statistical importance (p>0.05) (Fig. 9). 
Importantly, the number of adhered cells on woven and knitted PET-Hep-Col increased by 1.3 and 
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2 fold (P=0.02) compared to corresponding unmodified PET. This is in accordance with our data 
acquired from optical microscope after Giemsa stain shown in Figure 10. The adhered cells 
manifested the influence of collagen in promoting cell adhesion and growth on the modified 
grafts. 
 
Figures 9. The number of adhered L929 cells to PET grafts after 24h cell culturing. The adhered cells were 
counted (x10
4
 cell/cm
2
) after isolation from woven (black bars) and knitted (white bars) forms of; 
unmodified PET, PET-Hep and PET-Hep-Col. Results are given as mean ± standard deviation of three 
independent experiments. 
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Figure 10. Micrographs of Giemsa stained adhered L929 cells on PET grafts after 24h cell culture. Woven 
(A2) and knitted (B2) PET-Hep-Col obviously enhanced cell adhesion, while the corresponding woven (A) 
and knitted (B) of unmodified PET and woven (A1) and knitted (B1) PET-Hep showed lesser cell adhesion. 
 
4. Discussion  
Long-term patency rates of woven and knitted forms of crimped PET cardiovascular grafts are 
limited mainly due to inadequate endothelialization and surface induced thrombosis. The 
thrombogenic property of PET, mostly initiated by the adsorption of plasma proteins and by the 
platelets activation, is the common mode of failure of cardiovascular grafts after implantation [1, 
2, 3, 6]. 
Since the interactions that lead to thrombus formation occur at the graft-blood interface, the 
necessity of an appropriate surface modification is potential in improving the blood compatibility 
without altering the essential bulk properties of the graft for medical applications. One approach 
to reduce the surface thrombogenicity of the graft is to attach an anticoagulant molecule to the 
graft surface. In this study, we attempted to produce biocompatible graft by immobilization of 
heparin. Moreover, the combination of heparin and collagen presents synergic properties of 
thrombus resistance and cytocompatibility, therefore, the co-immobilization of heparin/collagen 
onto woven and knitted forms of crimped PET grafts was also investigated. 
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Heparin is the commonly used anticoagulant that forms a complex with anti-thrombin III. The 
heparin anti-thrombin III complex inactivates serine proteases, most importantly thrombin, which 
catalyzes the conversion of fibrinogen to fibrin in the final step of the coagulation cascade reaction 
[11]. In addition, collagen is the main component of the extracellular matrix on which the 
endothelial cells could adhere, proliferate, and differentiate [17]. However, the inert architecture 
of PET entails the functionalization of surface for immobilization purpose. Accordingly, to 
introduce carboxyl groups on the PET surface, the alkaline treatment of PET was utilized to 
cleavage the inherent ester linkages within the PET texture (Fig. 2) [18].  
The presence of the desired functional group on PET-COOH was proven using FTIR based on the 
appearance of broad shoulder of the hydroxyl group originating from carboxyl group [22] (Fig.3). 
One terminal amino group of ethylendiamine was grafted to the generated functional group on 
PET-COOH via an amide bond to form PET-NH2. The second amino group in ethylendiamine was 
further used as an anchor for heparin immobilization or heparin/collagen co-immobilization to 
produce PET-Hep or PET-Hep-Col, respectively. 
To avoid the reaction between amino and carboxyl groups of heparin molecules, or between 
heparin and collagen, glutaraldehyde was used to activate the amino groups on the surface of PET-
NH2. This ensured that the reaction occurred only on the desired group by end-point method.  
Quantitative analysis of atomic concentrations of studied grafts was calculated from XPS survey 
scan spectra (Table 1). The atomic concentration of carbon after modification was reduced due to 
the removal and loss of some molecules from the graft surface upon the alkaline treatment [18]. 
Furthermore, unlike unmodified PET, nitrogen and sulfur atoms were detected on PET-Hep and 
PET-Hep-Col confirming the successful co-immobilization of heparin and collagen. Similar results 
were obtained by comparing XPS spectra of native heparin and native collagen with PET, PET-Hep 
and PET-Hep-Col as shown in Figure 4. The XPS spectra of PET-Hep and PET-Hep-Col demonstrated 
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two peaks corresponding to nitrogen and sodium, while these peaks could not be detected in XPS 
spectra of unmodified PET thus, verifying the successful covalent co-immobilization of heparin and 
collagen. In accordance with XPS spectra of PET-Hep, the concentration of heparin on the surface 
as detected by toluidine blue assay indicated the effective immobilization of heparin on the 
surface. 
Our approach to immobilize heparin by the end-point provided the needful flexibility for optimum 
surface passivation. This is in agreement with previous reports showed that the end-point 
attached of heparin completely inhibited thrombin activity and the subsequent thrombus 
formation on the graft surface during the massive blood flow [23].  
Therefore, the biological activity of modified grafts was evaluated in-vitro under human-mimic 
conditions. The formation of clot on unmodified PET, PET-Hep and PET-Hep-Col was investigated 
by direct blood coagulation test. The results demonstrated intense clot after 10 minutes blood 
contact on unmodified PET surface. However, the fibrin deposition profile of unmodified PET 
presented wide net of fibrin fibers confirming highly thrombogenic characteristics at early time 
points as shown in the magnified images (Fig. 7). Unlike to unmodified graft, PET-Hep and PET-
Hep-Col exhibited substantial resistance to clot and fibrin formation. This is attributed to the 
neutralization effect of heparin on thrombin formation. Moreover, the activated platelets can only 
adhere and aggregate if significant blood proteins adsorb on the graft surface [6,7,24], 
consequently, the inhibition of fibrin precipitation on the surface decreased the number of 
activated platelets and hence its deposition. Based on this, the stimulation of anti-thrombin III by 
heparin along with inhibition of factor Xa prevented the conversion of pro-thrombin to thrombin. 
Subsequently, the protein adsorption and platelets deposition on the surface were decreased (Fig. 
5 and 6). Conversely, addition of collagen supported the protein adsorption to some extent on the 
PET surface and increased the number of deposited platelets. As a result, collagen restricts the 
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solitary use in the application for blood contacting biomaterials. Nevertheless, the co-
immobilization of heparin and collagen showed synergic inhibition effect of platelets deposition 
after 30 minutes continuous flow condition to simulate the massive blood flow which defines the 
outcomes of cardiovascular graft patency [4].  
Another potential strategy to limit short-term patency rate of cardiovascular grafts due to 
thrombus formation is by providing a rapid uniform and complete coverage with host cells [13, 16, 
17]. The muco-polysaccharide structure of heparin is a natural component of arterial cell wall that 
decreases the surface hydrophobicity and encourages cell adhesion on the graft surface [8, 9, 10, 
11]. This explained the insignificant increase in the number of the adhered cells on PET-Hep 
compared to unmodified PET (Fig. 9). Interestingly, collagen co-immobilization significantly 
enhanced the cell adhesion and growth by presenting a surface supplemented with natural 
connective component in endogenous extracellular matrix [17]. The beneficial effect of collagen 
on cell adhesion and growth was additionally confirmed by differential cell staining using Giemsa 
stain (Fig.10). This highly emphasized the enhancement of cell growth 5 days after cell culturing on 
PET-Hep-Col compared to either unmodified PET or PET-Hep (Fig.8). Notably, the cells displayed 
insignificant difference in growth pattern on woven and knitted forms of all tested grafts. The 
closed filaments in tightly woven and knitted forms enable the cells to bridge the distance 
between filaments. This confirmed the dependency of cell adhesion mainly on the surface 
properties [25, 26]. 
 
5. Conclusion 
Co-immobilization of heparin and collagen on crimped PET grafts minimized the host response 
reactions on the graft surface and ensured a rapid coating of grafts with host cells. The reported 
anti-thrombus potential of the modified grafts highlights the utility of our strategy to treat the 
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common complications after implantation and to produce biocompatible crimped PET grafts for 
medical application.  
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Summary discussion 
Cardiovascular prostheses successfully restore the function of damaged vessels and cardiac valves 
[1,2,3]. Despite of the associated complications with polyethylene terephthalate (PET) grafts, the 
woven and knitted forms of crimped PET grafts are still the most effective employed biomaterials 
[1,2,3]. However, infections and the host response destruct the graft and damage the surrounding 
tissue which often necessitates graft removal upon surgical operation [4,5].In this study, we took 
priority over coating the crimped PET grafts with a newly synthesized SD-PHA-b-MPEO diblock co-
polymer, utilizing its multifunctional advantages mainly negative charge, hydrophobicity, and the 
bactericidal effect of the sulfadimethoxine (SD) moiety. The structure of the employed polymer 
was proven and characterized using nuclear magnetic resonance (NMR), infrared (IR) and UV 
spectroscopy before use [6]. We intended to form a porous film to maintain the tensile ability of 
the grafts by evaporating the water-immiscible polymer solvent under saturated humid 
atmosphere [7]. The formed network architecture film displayed a local bactericidal effect while 
attaining suitable characteristics to PET surface in terms of cell adhesion and growth, which hold 
promise for sufficient coverage of the graft with host cell. This consideration is based on the fact 
that the adhesion and growth of the host cell on PET depend on surface hydrophobicity, porosity, 
electronegativity, mechanical properties, and in particular the distance between individual 
filaments in the yarn [8,9]. Accordingly, the hydrophobic block of the polymer and the negative 
charge on its surface hampered the cell adhesion to a small non-significant extent. In contrast, the 
formed network-structured coat provided a benefit to reduce the interval distance between the 
discrete filaments in the yarn. Additionally, the hydrophilic block of the polymer supported cell 
adhesion and growth and enabled the cells to bridge the filaments [8].  As a result, L929 cells 
readily overgrew the coated PET (PET-Net) and a cellular monolayer was observed after 7 days.  
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The In-vitro calculated anti-adhesion efficiency of PET-Net against three different bacterial strains, 
namely S. epidermidis, S. aureus, and E. coli representing the most common Gram-positive and 
Gram-negative pathogens indicated highly significant reduction on adhesion of all aforementioned 
strains compared to unmodified PET (P=0.003). Notably, we reinforced our results by using a 
violent pathogenic Gram-positive S. epidermidis strain previously isolated from a patient`s vein 
catheter. Indeed, bacteria tend to adhere on and colonize preferably neutral and hydrophilic 
rather than hydrophobic surfaces [4]. This is avoided in the presence of polyhexylene and 
sulfadimethoxine groups in the formed multifunctional coat which switch the surface into 
hydrophobic and render the graft surface negatively charged. Additionally, the bacterial cell-
repelling characteristics of polyethylene oxide guided synergistic antibacterial effect of the 
sulfadimethoxine group that make the modified PET graft even more unsuitable for bacterial 
adhesion and colonization. Furthermore, bacterial adhesion could be influenced not only by 
electronegativity and hydrophobicity but also by surface porosity [10,11]. Therefore, the low 
porosity of the PET-Net makes it less favorable to bacterial adhesion. 
 
In the second study: we modified PET grafts with the lysozyme to take advantage of its capacity to 
lyse β (1- 4) glucosidic bonds in the bacterial cell wall, resulting in an effective protection against 
bacterial adhesion and biofilm formation. The ligation of lysozyme on surfaces of woven and 
knitted forms of crimped PET cardiovascular grafts was confirmed by XPS spectra of native 
lysozyme and unmodified PET versus enzyme-immobilized PET (PET-Enz). Despite a minor 
reduction of the immobilized enzyme activity on woven and knitted PET grafts compared to free 
enzyme, we found obvious anti-adhesion efficiency of the immobilized enzyme against Gram-
positive S. aureus, S. epidermidis, and Gram-negative E. coli bacterial strains.  
The results demonstrated a better activity of PET-Enz grafts against Gram-positive than Gram-
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negative bacteria. This attributed to that lysozyme, a glycoside hydrolase, cleaves the β (1- 4) 
glucosidic bond between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in 
peptidoglycan of bacterial cell wall [12,13]. The targeted glucosidic β(1-4) bonds in a Gram-positive 
cell wall are uncovered and found in large quantities compared to the Gram-negative cell wall 
which contains an outer membrane [14]. Consequently, the enzyme on PET-Enz grafts can easily 
access these structures on Gram-positive bacteria, leading to pressure imbalance within the 
bacterial cell wall causing cell lysis and death, a finding that promises eradication of subsequent 
biofilm formation [13,14,15]. In contrast, in the outer membrane of Gram-negative bacteria, the β 
(1- 4) glucosidic bonds are hidden under a layer of lipoproteins and only few exist in the pili on the 
cell surface. Accordingly, the enzyme activity is limited mainly to the pili and the burdened 
bacterial adhesion without any effect on the wall structure [13,14,15]. Our PET-Enz grafts still 
retained activity against Gram-negative bacteria, may be explained by earlier findings stating that 
the irreversibly inactivated lysozyme showed antibacterial effects, suggesting that the 
antibacterial efficiency is not only attributable to its activity, but also to the alkaline nature of the 
enzyme [15]. In our study, woven grafts were more hospitable to bacterial adhesion than knitted 
grafts. Bacterial adhesion could, in theory, be influenced by factors other than lysozyme including 
graft porosity, surface tension, and electronegativity [16]. According to our results, the lower 
porosity of the woven PET may make it more favorable to bacteria adhesion. To ensure complete 
healing after graft implantation, coating of the graft by the natural host cells is critical. This 
process can be disturbed by successful bacterial adhesion and biofilm formation on the grafts 
surface. All PET grafts in our study were readily overgrown by L929 cells used as a model to 
evaluate the cell hosting. No significant difference in the number of attached cells after enzyme 
immobilization was observed. A trend towards an increased number of adhered cells on PET-Enz 
graft due to modulated surface hydrophobicity by lysozyme compared to unmodified grafts 
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showed no statistical significance.  Altogether, these findings outline conformity of the modified 
grafts with the biocompatibility requirements for biomedical applications.  
 
In the third study: we aimed to support the grafts patency by local delivery of hydrophilic drugs 
using PLGA nanoparticles as carrier and FITC-dextran (FD) as water soluble drug model. The 
nanoparticles (NPs) were covalently immobilized to PET and expanded polytetrafluoroethylene 
(ePTFE) grafts after surface functionalization. The functional amino group was directly produced 
on PET by aminolysis reaction using ethylendiamine to selectively cleavage of the ester bond 
within the PET surface [17]. Characterization of the aminolated graft by surface potential 
measurement demonstrated a negative potential over a wide pH range due to ionization of the 
surface amino group with an isoelectric point at around pH 7-8 conforming the successful amino 
functionalization [18]. While ePTFE was amino-functionalized by grafting 3-aminopropyl 
triethoxysilane to the previously produced hydroxyl groups using piranha solution [19]. The 
introducing of amino group on ePTFE was proven using FTIR corresponding to the definite band of 
amino group [20]. Afterwards, the produced amino groups on the surfaces were activated by 
glutaraldehyde and used further as anchor sites for covalent coupling to the carboxyl group in the 
PLGA nanoparticles. The nanoparticles were synthesized from biodegradable PLGA polymer for 
local, controlled release, taking advantages of the high capacity of hydrophilic drugs by double 
emulsion-solvent evaporation method and the stability of obtained particles [21].  
Additionally, for immobilization purpose, the intrinsic carboxyl groups in the PLGA made it our first 
choice for nanoparticles syntheses along with Tween®80 as surfactant at suitable concentration to 
stabilize the nano suspension. The surfactant adsorb at the particles surface between the 
superficially COOH groups leaving them free and available for coupling [22]. The marked increase 
in the size of the obtained FD-loaded NPs in comparison to unloaded NPs is attributed to 
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expansion of polymeric matrix within FD encapsulation [22]. However, all particles seemed to 
possess the ideal surface charge suggesting that the surfactant and/or FITC-dextran have no 
masking effect on the superficial carboxylic groups [23].  
However, the efficiency of nanoparticles coating for cardiovascular grafts entails the stability 
during the massive blood flow to secure the local controlled release of encapsulated drug. 
Therefore, the stability of immobilized NPs was evaluated in-vitro under human-mimic conditions. 
The surface visualization manifested permanence of monolayer coat on nano-immobilized grafts 
(PET-NPs and ePTFE-NPs) after 24h substantial continuous flow providing an appropriate carrier 
for controlled drug delivery over the tested time. Nonetheless, the ability of PET-NPs and ePTFE-
NPs to support host cell adhesion and growth is decisive and displayed dependency on surface 
topography, hydrophobicity, and porosity [24,25]. Interestingly, the tested grafts were readily 
overgrown by L929 cells and shown no significant difference in the number of adhered cells on 
PET-NPs and ePTFE-NPs compared to unmodified grafts. Furthermore, the hosting ability of the 
modified grafts was additionally confirmed by differential cell staining using Giemsa stain. This 
highly emphasized the conformity of the nano-immobilized grafts with the biocompatibility 
requirements for biomedical applications.  
 
In the fourth study: we attempted to produce biocompatible graft by immobilization of heparin. 
Moreover, the combination of heparin and collagen presents synergic properties of thrombus 
resistance and cytocompatibility, therefore, the co-immobilization of heparin/collagen onto woven 
and knitted forms of crimped PET grafts was also investigated. Heparin is the commonly used 
anticoagulant that forms a complex with anti-thrombin III. The heparin anti-thrombin III complex 
inactivates serine proteases, most importantly thrombin, which catalyzes the conversion of 
fibrinogen to fibrin in the final step of the coagulation cascade reaction [26]. In addition, collagen 
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is the main component of the extracellular matrix on which the endothelial cells could adhere, 
proliferate, and differentiate [27]. However, the inert architecture of PET entails the 
functionalization of surface for immobilization purpose.  The successful covalent co-immobilization 
of heparin and collagen was confirmed by XPS spectra of heparin-immobilized PET (PET-Hep) and 
heparin/collagen co-immobilized PET (PET-Hep-Col). In accordance with XPS spectra of PET-Hep, 
the concentration of heparin on the surface as detected by toluidine blue assay indicated the 
effective immobilization of heparin on the surface. Therefore, the biological activity of modified 
grafts was evaluated in-vitro under human-mimic conditions. 
The results demonstrated intense clot after 10 minutes blood contact on unmodified PET surface. 
However, the fibrin deposition profile of unmodified PET presented wide net of fibrin fibers 
confirming highly thrombogenic characteristics at early time points. Unlike to unmodified graft, 
PET-Hep and PET-Hep-Col exhibited substantial resistance to clot and fibrin formation. This is 
attributed to the neutralization effect of heparin on thrombin formation. Moreover, the activated 
platelets can only adhere and aggregate if significant blood proteins adsorb on the graft surface 
[5,28,29], consequently, the inhibition of fibrin precipitation on the surface decreased the number 
of activated platelets and hence its deposition. Based on this, the stimulation of anti-thrombin III 
by heparin along with inhibition of factor Xa prevented the conversion of pro-thrombin to 
thrombin. Subsequently, the protein adsorption and platelets deposition on the surface were 
decreased. Conversely, addition of collagen supported the protein adsorption to some extent on 
the PET surface and increased the number of deposited platelets. As a result, collagen restricts the 
solitary use in the application for blood contacting biomaterials. Nevertheless, the co-
immobilization of heparin and collagen showed synergic inhibition effect of platelets deposition 
after 30 minutes continuous flow condition which defines the cardiovascular graft patency. 
Otherwise, the mucopolysaccharide structure of heparin is a natural component of arterial cell 
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wall that decreases the surface hydrophobicity and encourages cell adhesion on the graft surface 
[27,30,31]. This explained the insignificant increase in the number of the adhered cells on PET-Hep 
compared to unmodified PET. Interestingly, collagen co-immobilization significantly enhanced the 
cell adhesion and growth by presenting a surface supplemented with natural connective 
component in endogenous extracellular matrix [28]. The beneficial effect of collagen on cell 
adhesion and growth was additionally confirmed by differential cell staining using Giemsa stain. 
This highly emphasized the enhancement of cell growth 5 days after cell culturing on PET-Hep-Col 
compared to either unmodified PET or PET-Hep. This confirmed the dependency of cell adhesion 
mainly on the surface properties. 
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Perspective 
Prosthetic medical grafts, particularly, PET cardiovascular grafts have become an essential part of 
modern medicine and acquired an enlarged interests due to the significant improvement of 
patient's life quality after grafts implantation. However, development the quality and stability of 
implanted PET are still considered as the most challenges for prosthetic cardiovascular grafts. We 
attempted in this thesis to improve the biocompatibility and the resistance to infection of PET 
grafts in aim to increase the PET long-term patency. The employed strategies revealed an effective 
bacterial anti-adhesion efficiency by the network-structured polymer film coat, and to a higher 
extent, by lysozyme enzyme immobilization. The biocompatibility of the modified grafts was also 
established to offer anti-thrombotic PET grafts that ensure the rapid host healing. Furthermore, 
synergistic inhibition of platelets deposition and fibrin formation was accomplished by co-
immobilization of heparin and collagen on the graft’s surface.  The heamocompatibility of the 
performed PET grafts showed fast natural host cell coverage. Interestingly, the coating of 
cardiovascular grafts with nanoparticles demonstrated advantageous model to load suitable drugs 
for treatment of the common complications after implantation.  
Nevertheless, we are still encouraged for advanced studies proposed to evaluate the activity of 
immobilized nanoparticles in terms of local drug release, and finally, to investigate the proficiency 
of the described strategies in-vivo.    
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Zusammenfassende Diskussion 
Kardiovaskuläre Prothesen stellen die Funktion  beschädigter Gefäße und Herzklappen wieder her 
[1,2,3]. Solche Prothesen aus geknäueltem PET Gewebe sind, trotz der mit ihm verbundenen 
Komplikationen, das effektivste eingesetzte Biomaterial [1,2,3]. Infektionen und Reaktionen des 
Patienten beschädigen jedoch oft Implantat und umliegendes Gewebe, so dass ein Ersatz des 
Implantates nötig wird [4,5]. In der vorliegenden Arbeit wurden PET Implantate mit einem neu 
synthetisierten SD-PHA-b-MPEO-Diblock-Polymer beschichtet, dessen Vorteile seine negative 
Ladung, die Hydrophobizität und die antibakterielle Wirkung der Sulfadimethoxin (SD) Einheit sind. 
Die Struktur der eingesetzten Polymere wurde, vor ihrer Verwendung, durch 
Kernresonanzspektroskopie (NMR), sowie IR und UV Spektroskopie überprüft [6].  
Wir beabsichtigten die Bildung eines porösen Filmes, durch welchen die mechanischen 
Eigenschaften des Implantates erhalten bleiben. Die Bildung des Filmes erfolgt durch 
Verdampfung einer wasserunlöslichen Polymerlösung in gesättigter Atmosphäre. Der gebildete 
Film besitzt antibakterielle Eigenschaften und verschafft dem PET-Implantat günstige 
Eigenschaften in Bezug auf  Zelladhäsion und Wachstum. Dies ist vielversprechend für das 
Erreichen einer hohen Bedeckung des Implantates mit  autologen Zellen. Die zugrundeliegenden 
Überlegungen basieren darauf,  dass Adhäsion und Wachstum von Zellen auf einer PET-Oberfläche 
von mehreren Faktoren abhängen.  Dies sind die Hydrophobizität, die  Porosität, die 
Elektronegativität, die mechanische Eigenschafen und, im Besonderen, der Abstand zwischen den 
Fäden des Gewebes [8,9]. Der hydrophobe Anteil des Block-Polymers sowie die negativen 
Ladungen behindern die Zelladhäsion nur in geringem, nicht signifikantem, Ausmaß.  Darüber 
hinaus hilft die gebildete Beschichtung, die Abstände innerhalb des Gewebes zu verkürzen. Das 
geht so nicht raus. Im Ergebnis überwucherten L929-Zellen das beschichtete PET (PET-Netz) und 
eine Monolage aus Zellen konnte nach 7 Tagen erreicht werden. 
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Die, In-Vitro bestimmte, antiadhäsive Wirkung des PET-Netzes gegen 3 verschiedene 
Bakterienstämme, S. epidermidis, S. aureus und E. Coli (Repräsentativ für die häufigsten Gram-
positiven und Gram-negativen Pathogene) zeigte eine hochsignifikante Reduktion der Adhäsion 
aller voranstehend genannten Stämme, verglichen mit unmodifiziertem PET (P=0.003). Wir 
bestätigten unsere Ergebnisse durch Verwendung eines aggressiven pathogenen Stammes Gram-
Positiver S. epidermidis, welcher aus dem Venenkatheter eines Patienten isoliert wurde. In der Tat 
tendieren Bakterien eher zur Anlagerung und Koloniebildung auf neutralen und hydrophilen als 
auf hydrophoben Oberflächen [4]. Dies wird durch das Vorhandensein von Polyhexylen und 
Sulfadimethoxin-Gruppen in der gebildeten Beschichtung verhindert, durch welche die Oberfläche 
Hydrophob und negativ geladen wird. Darüber hinaus unterstützt die Bakterien-abstoßende 
Wirkung des Polyethylen-Oxids die antibakterielle Wirkung der Sulfadimethoxin-Gruppen, 
wodurch die Oberfläche des Gewebes noch ungeeigneter für die Anhaftung von Bakterien wird. 
Darüber hinaus kann die Adhäsion von Bakterien nicht nur durch Elektronegativtät und 
Hydrophobizität, sondern auch durch Porosität der Oberfläche beeinflusst werden [10,11]. Die 
geringe Porosität des PET-Netzes ist für bakterielle Adhäsion weniger günstig. 
 
In der zweiten Studie wurde PET-Gewebe mit Lysozym modifiziert, um die Eigenschaft des 
Lysozyms, ß(1-4)glykosidische Bindungen zu spalten, zu nutzen. Die Spaltung dieser Bindung in der 
bakteriellen Zellwand bewirkt einen effektiven Schutz gegen bakterielle Adhäsion und 
Biofilmbildung. Die Anbindung des Lysozym auf die Oberfläche des kardiovaskulären PET-
Implantates wurde mittels XPS-Spektren  von nativem Lysozym und unmodifiziertem PET im 
Vergleich mit PET-gebundenem Enzym überprüft. Trotz einer leicht verminderten enzymatischen 
Aktivität des gebundenen Enzyms, verglichen mit dem freien Enzym, wurden eine offensichtliche 
anti-adhäsive Wirkung des immobilisierten Enzyms gegen Gram-Positive S. aureus, S. epidermidis 
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und Gram-negative E.coli festgestellt. Die Ergebnisse zeigten eine besser Aktivität des PET-Enzym-
Gewebes gegen Gram-positive als gegen Gram-Negative Bakterien. Dies ist darauf zurückzuführen, 
das Lysozym, eine Glykosid-Hydrolase, die ß(1-4)-glykosydische Bindung zwischen N-
Acetylmuraminsäure und N-Acetyl-D-Glucosamin-Resten im Peptidoglycan der bakteriellen 
Zellwand spaltet [12,13]. Die anvisierten ß(1-4)-glykosydische Bindungen sind in gram-positiven 
Bakterien und in großer Zahl vorhanden, wohingegen sie bei Gram-Negativen Bakterien durch eine 
äußere Membran geschützt sind [14]. In Folge dessen haben die Enzyme auf dem PET-Gewebe 
leichten Zugang zu den Strukturen bei Gram-negativen Bakterien, was zum Abbau der bakteriellen 
Zellwand und somit auch zu Zell-Lyse und Tode der Bakterien führt. Diese Erkenntnis verspricht 
eine Verhinderung der Bakterien-Film-Bildung [13,14,15]. Im Gegensatz dazu sind die ß(1-4)-
glykosydischen Bindungen in der Zellwand Gram-negativer Bakterien unter einer Schicht von 
Lipoproteinen verborgen, und nur wenige dieser Bindungen befinden sich in den Pili an der 
Oberfläche. Daher beschränkt sich in diesem Fall die enzymatische Wirkung auf die Pili und die 
bakterielle Adhäsion, jedoch ohne Effekt auf die Struktur der Zellwand [13,14,15]. Das neu 
hergestellte PET-Enzym-Gewebe trotzdem Wirkung gegen Gram-Negative Bakterien zeigt, könnte 
dadurch erklärt werden, das selbst irreversibel inaktiviertes Lysozym antibakterielle Wirksamkeit 
besitzt, was nahelegt, das die Wirkung nicht nur auf Enzymaktivität sondern auch auf dem 
basischen Charakter des Enzyms beruht [15]. 
In unserer Studie zeigte sich, dass gewebtes Implantat Material für die Anhaftung von Bakterien 
weitaus besser prädestiniert ist als gestricktes Material. Bakterielle Adhäsion könnte theoretisch 
auch durch andere Faktoren als Lysozym, wie zum Beispiel Porosität des Gewebes, 
Oberflächenspannung und Elektronegativität beeinflusst worden sein[16]. Nach unseren 
Ergebnissen macht die geringe Porosität des gewebten PET es geeigneter für die Anhaftung von 
Bakterien. Um ein vollständiges Einwachsen des Implantates zu gewährleisten, ist es wichtig, dass 
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das Implantat vollständig von den Zellen des Patienten bedeckt wird. Dieser Vorgang kann durch 
die Anlagerung von Bakterien und die Ausbildung eines Biofilmes gestört werden. Alle in dieser 
Studie genutzten PET-Gewebe wurden von L929-Zelle, welche als Modell genutzt wurden, zügig 
überwuchert. Nach Immobilisierung des Enzyms wurde kein signifikanter Unterschied in der Zahl 
der anhaftenden Zellen festgestellt. Ein Trend zu einer erhöhte Anzahl anhaftender Zellen auf PET-
Enzym-Gewebe zeigte keine statistische Signifikanz. Zusammengefasst gesagt sind die Ergebnisse 
konforme mit den Biokompatibilitäts-Anforderungen an Gewebe für medizinische Anwendungen. 
 
In der dritten Studie konzentrierten wir uns auf Erhöhung der  Durchlässigkeit des Gewebes durch 
lokales Einbringen hydrophiler Substanzen mittels bioabbaubarer PLGA-Nanopartikel als Träger 
und mit FITC-Dextran (FD) als wasserlösliches Drug-Model. Die Nanopartikel wurden kovalent auf 
PET-Gewebe und auf ePTFE (expanded PTFE)-Gewebe, nach Oberflächenfunktionalisierung, 
immobilisiert. Die funktionellen Aminogruppen wurden direkt auf dem PET, durch Aminolyse-
Reaktion unter Verwendung von Ethylendiamin zur selektiven Spaltung der Esterbindungen in der 
PET-Oberflächen [17]dargestellt.  Die Charakterisierung des aminolierten Gewebes durch Messung 
des Oberflächenpotentials zeigte ein negatives Potential über einen weiten pH-Bereich, bedingt 
durch Ionisation der an der Oberfläche befindlichen Aminogruppen mit isoelektrischem Punkt um 
pH= 7-8, und bestätigte somit die erfolgreiche Funktionalisierung. ePTFE wurde durch Reaktion 
von 3-Aminopropyl Triethoxysilan, unter Zuhilfenahme von Piranha-Lösung, mit vorher 
dargestellten OH-Gruppen funktionalisiert. Der Erfolg der Einführung der Aminogruppe auf ePTFE 
konnte mittels FTIR gezeigt werden, wobei die charakteristische Amino-Bande darstellbar war 
[20]. Im Anschluss daran wurden die Aminogruppen auf der Oberfläche mittels Glutaraldehyd 
aktiviert und als Ankerstellen für die kovalente Anbindung von Carboxylgruppen der PGLA-
Nanopartikel benutzt. Die Nanopartikel wurden aus bioabbaubarem PLGA-Polymer hergestellt. 
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Das Ziel war eine lokale, kontrollierten Freisetzung der in den Partikeln enthaltenen hydrophilen 
Wirkstoffe sowie eine hohe Stabilität der erhaltenen Partikel. Die PLGA Nanopartikelsuspension 
wurde vor der Immobilisierung an der Implantat Oberfläche erstmals mit Tween 80  stabilisiert. 
Der Anstieg in der Größe der FD-beladenen Nanopartikel im Vergleich mit unbeladenem 
Nanopartikeln ist durch Erweiterung der Polymermatrix bei FD-Einbau bedingt [22]. Alle Partikel 
besitzen eine ideale Oberflächenladung, was darauf hindeutet, dass das Tensid und\oder FD-
Dextran keine maskierenden Einfluss auf die Carboxylgruppen an der Oberfläche ausüben [23]. 
Die Effektivität der Bedeckung kardiovaskulärer Implantate mit Nanopartikeln hängt auch davon 
ab, ob bei starkem Blutfluss eine lokale, kontrollierte Freisetzung der eingeschlossenen Wirkstoffe 
erreicht wird. Deshalb wurde die Stabilität der Nanopartikel in vitro, unter Bedingungen, die 
denen im Menschen vergleichbar sind, getestet. Die gezeigte Stabilität der Monolayer-
Oberflächenbeschichtung auf Nano-Immobilisierten Implantaten (PET-NPs und ePTFE-NPs) nach 
24 Stunden starkem, kontinuierlichem Fluss zeigt, dass diese ein geeigneter Träger für 
kontrollierten Wirkstofftransport über den Testzeitraum sind.  Nichtsdestotrotz ist die Fähigkeit 
von PET-NPs und ePTFE-NPs zur Unterstützung der Anhaftung von Wirtszellen entscheidend und 
abhängig von der Oberflächentopographie, Hydrophobizität und Porosität [24,25]. 
Interessanterweise wurde die getesteten Implantate von den L929-Zellen zügig überwachsen und 
es trat keine signifikanter Unterschied in der Zahl anhaftender Zellen zwischen PET-NPs und 
ePTFE-NPs, verglichen mit unmodifizierten Transplantaten, auf. Dies unterstreicht deutlich, dass 
die Nano-immobilisierten Implantate mit den Biokompatibilitäts-Anforderungen für 
biomedizinische Anwendung konform gehen. 
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In der vierten Studie  versuchten wir, biokompatible Transplantate durch Immobilisierung von 
Heparin herzustellen. Die Kombination aus Heparin und Kollagen besitzt synergistische 
Eigenschaften bei Thrombus-Resistenz und Zellverträglichkeit, daher wurde die Co-Immobilisation 
von Heparin und Collagen auf Transplantaten aus gewebtem und geknäueltem PET untersucht. 
Heparin ist das am häufigsten verwendete Antikoagulanz und bildet einen Komplex mit 
Antithrombin III. Der Heparin-Antithrombin III-Komplex inaktiviert Serinproteasen (hauptsächlich 
Thrombin) welche die Umwandlung von Fibrinogen in Fibrin im letzten Schritt der 
Gerinnungskaskade katalysiert [26]. Zusätzlich ist Kollagen die Hauptkomponente der 
extrazellulären Matrix, auf welcher die Endothelzellen anhaften, proliferieren und differenzieren 
können [27]. Die inerte Struktur der PET-Oberfläche macht eine Funktionalisierung für 
Immobilisierungen erforderlich. Der Erfolg der Co-Immobilisation von Heparin und Collagen wurde 
durch XPS-Spektren von PET mit immobilisiertem Heparin (PET-Hep) und PET mit co-
immobilisiertem Heparin\Collagen (PET-Hep-Col) bestätigt. In Übereinstimmung mit den XPS-
Spektren von PET-Hep, bestätigte die durch Toluidin-Blau-Anfärbung bestimmte 
Oberflächenkonzentration die effektive Immobilisierung von Heparin an der Oberfläche. Deshalb 
wurde die biologische Aktivität der modifizierten Transplantate in Vitro unter Menschen-
Ähnlichen Bedingungen bestimmt. 
Die Ergebnisse zeigen eine starke Thrombusformation auf unmodifizierter PET-Oberfläche nach ca. 
10 Minuten. Das Verteilungsmuster von Fibrin auf unmodifiziertem PET zeigt ein weites Netz von 
Fibrins-Faser, was auf hohe thrombogene Eigenschaften schon zu frühem Zeitpunkt hinweist. 
Anders als bei unmodifizierten Implantaten, zeigten PET-Hep und PET-Hep-Col eine merkliche 
Resistenz gegen Thrombusbildung und Fibrinadhäsion. Die wird auf den hemmenden Effekt des 
Heparins auf die Thrombin-Bildung zurückgeführt. Darüber hinaus, können die aktivierten 
Plättchen sich nur dann anlagern und aggregieren, wenn signifikante Blutproteine sich auf der 
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Oberfläche anlagern [5,28,29]. Demzufolge senkt die Inhibierung der Fibrin Adhäsion die Anzahl 
und Ablagerung aktivierter Plättchen. Darauf basierend, verhinderte die Stimulation von Anti-
Thrombin III durch Heparin, zusammen mit der Inhibierung von Faktor Xa, die Umwandlung von 
pro-Thrombin in Thrombin. Infolge dessen wurden die Proteinabsorption und die Plättchen-
Ablagerung auf der Oberfläche vermindert. Im Gegensatz dazu wirkte das Hinzufügen von Collagen 
zur PET-Oberfläche zu einem gewissen Grads unterstützend auf die Proteinadsorption und 
erhöhte die Zahl der angelagerten Plättchen. Das Ergebnis hiervon ist, das Collagen als alleinige 
Oberflächenbeschichtung von Biomaterialien, die Kontakt mit Blut haben, ungeeignet ist. Dennoch 
zeigt die Co-Immobilisierung von Heparin und Collagen einen synergetischen inhibierenden Effekt 
auf die Anlagerung von Plättchen nach 30 Minuten kontinuierlichem Fluss, was die 
Durchgängigkeit des kardiovaskulären Implantates ausmacht. 
Die Polysacharidstruktur des Heparins ist ein natürlicher Bestandteil der arteriellen Zellwand, 
welcher die Hydrophobizität senkt und Zelladhäsion auf der Oberfläche des Transplantates 
erleichtert [27,30,31]. Dies erklärt den insignifikanten Anstieg der Zahl anhaftender Zellen auf PET-
Hep im Vergleich mit unmodifiziertem PET. Interessanterweise erhöhte Collagen-Co-
Immobilisierung die Zelladhäsion und Wachstum signifikant, indem eine Oberfläche mit einem 
Anbindungspunkt, welcher auf in der endogen zellulären Matrix vorkommt, geschafften wird [28]. 
Der begünstigende Einfluss des Kollagens auf Zellanhaftung und Wachstum wurde durch Giemsa-
Färbung zusätzlich bestätigt. Durch die Verbesserung des Zellwachstums nach 5 Tagen aus PET-
Hep-Col im Vergleich mit unmodifiziertem PET und PET-Hep wird dies unterstrichen. Es bestätigt 
sich, dass die Zelladhäsion vor allem von den Eigenschaften der Oberfläche abhängt. 
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Ausblick 
Künstliche medizinische Implantate, insbesondere Herz-Kreislauf Implantate aus PET, sind zu 
einem wesentlichen Bestandteil der modernen Medizin geworden und erlangen ein stetig  
vergrößertes Interesse aufgrund der deutlichen Verbesserung der Lebensqualität des Patienten 
nach Implantation. Allerdings gelten die Verbesserung der Qualität und der Stabilität von PET 
Implantaten immer als Herausforderungen im Bereich der künstlichen Herz-Kreislauf Implantate. 
In dieser Arbeit konnten wir die Biokompatibilität und das Infektionsrisiko von PET Implantate 
verbessern, mit dem Ziel, die langfristige Verträglichkeit  zu steigen. Die eingesetzten Strategien 
zeigten einen wirksamen antiadhäsiven Effekt auf Bakterien durch den netzwerkartigen 
multifunktionalen Oberflächenüberzug und zu einem höheren Grad durch Lysozym 
Immobilisierung. Die Biokompatibilität der modifizierten Transplantate zeigte auch einen 
antithrombotischen Effekt der PET Implantate, der eine schnelle Heilung gewährleistete. 
Weiterhin wurde die Thrombozyten- und Fibrinanlagerung durch synergistische Co-
Immobilisierung von Heparin und Kollagen auf der Implantatoberfläche vermindert. Die 
Blutverträglichkeit der hergestellten PET Implantate führte zu einer schnellen Besiedelung mit 
Zellen des Zielgewebes. Interessanterweise erwies sich die Beschichtung von kardiovaskulären 
Implantaten mit Nanopartikeln als eine geeignete Methode Arzneistoffe zur Behandlung der 
häufigsten Komplikationen nach der Implantation freizusetzten. 
Dennoch sind immer noch weiterführenden Studien nötig, um die Freisetzungseigenschaften der 
immobilisierten Nanopartikel für die lokalen Wirkstoffabgabe zu untersuchen und letztendlich die 
beschriebenen Modelle in vivo zu testen.  
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Summary 
In chapter 1: Polyethylene terephthalate (PET) is considered as the gold standard cardiovascular 
graft to restore the function of damaged vessels and heart valves. However, the post implantation 
complications essentially distract the long-term patency of PET grafts resulting in prolonged 
hospitalization, graft failure, and patient death. Most of the prominent shortcomings of PET are 
the substantial thrombogenic property and the associated infections as well as the 
biocompatibility issues.  Therefore, in this thesis, the improvement of the biocompatibility and the 
infection-resistance properties of PET grafts were our foremost perspective. We fundamentally 
minimized the bacterial adhesion and enhanced the biocompatibility of woven and knitted forms 
of crimped PET cardiovascular grafts. Our results proved an effective strategy for graft surface 
modification in terms of biocompatible and infection-resistant.  
 
In chapter 2: the initial bacterial adhesion was minimized by a multifunctional network-structured 
film coat using a newly synthesized amphiphilic SD-PHA-b-MPEO diblock copolymer.  A versatile 
coating technique was described based on the repulsion forces between the surface and the used 
polymer to preserve the flexibility and tensile ability of crimped PET grafts. The surface modified 
graft was confirmed by Fourier transform infrared spectroscopy (FTIR) and by scanning electron 
microscope (SEM). The employed polymer manifested suitable biocompatibility to host cell as 
established using mouse L929 fibroblast cell line. Importantly, the negative charge and the 
hydrophobic properties of the polymer augmented the bactericidal effect of the sulfadimethoxine 
moiety as reported by the  significant bacterial anti-adhesion efficiency for Gram-positive S. aureus 
and Gram-negative E. coli bacteria, and for the previously vein isolated Gram-positive S. 
epidermidis.  
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In chapter 3: Unlike previous studies, the bacterial adhesion was enzymatically inhibited using a 
bacterial lytic enzyme, lysozyme. Accordingly, graft with broad-spectrum bacteria-resistant was 
developed. The lysozyme enzyme was covalently immobilized on PET graft by end-point method 
and proved by FTIR and X-ray photoelectron spectroscopy (XPS). The activity of immobilized 
enzyme against M. lysodeikticus cells displayed a significant reduction as compared to the free 
enzyme. However, the remaining activity remarkably decreased the adhesion of Gram-positive S. 
epidermidis and S. aureus bacteria and to less extent of Gram-negative E.coli. The anti-adhesion 
efficiency showed bacterial cells specificity while, showed no significant effect on L929 cells 
adhesion and growth. This indicated the utility of the employed strategy to modulate the initial 
bacteria adhesion to inhibit the graft-associated infection. 
 
In chapter 4: FITC-dextran loaded Poly lactic-glycolic acid (PLGA) nanoparticles were covalently 
immobilized onto two different cardiovascular prostheses namely; woven crimped PET and 
expanded polytetrafluoroethylene (ePTFE, Teflon®). The grafts surface was modified by 
introduction of amino groups on the surface. The surface modified graft was characterized by 
electro kinetic analyzer, and FTIR before the covalent coupling to the carboxyl group of PLGA 
Nanoparticles was performed. The prepared model manifested homogenous monolayer of 
nanoparticles on grafts surface and displayed a satisfactory stability under appropriate human-
mimic continuous flow conditions for 24h. Additionally, the established biocompatibility of nano-
coated grafts highlighted the utility of the immobilized nanoparticles on the graft’s surface as an 
attractive strategy for local drug delivery to treat the common complications after graft’s 
implantation, and hence increasing the grafts long-term patency. 
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In chapter 5: A thrombus-resistant graft was developed by covalent immobilization of heparin. 
Additionally, the host cell compatibility of PET grafts was enhanced by co-immobilization of 
collagen.  Heparin and collagen were immobilized by end-point method into previously 
functionalized PET grafts and characterized using FTIR and XPS. The modified grafts manifested a 
significant biological activity in-vitro under human-mimic conditions mainly, substantial resistance 
of the graft to clot and fibrin formation. Importantly, the co-immobilization of heparin and 
collagen supported the host cell adhesion and growth, and showed synergistic inhibition effect of 
platelets deposition after continuous flow for 30 minutes to simulate the massive blood flow 
conditions.  Consequently, this approach minimized the inherent thrombogenicity of the PET 
grafts and the corresponding host response, hence ensuring a rapid coating of grafts with host 
cells required for the grafts biocompatibility. 
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Zusammenfassung 
Im Kapitel 1 Polyethylenterephthalat (PET) wird als der Goldstandard in der Therapie mit 
kardiovaskulären Implantaten wie z.B. künstlichen Herzklappen oder Gefäßen angesehen. 
Trotzdem gibt es Komplikationen nach der Implantation, die erhebliche Probleme in der Langzeit-
Anwendung verursachen, wie z.B. Krankenhausaufenthalte, undichte Implantate oder sogar Tod 
des Patienten. Hierbei sind die am häufigsten auftretenden Probleme von PET die 
Biokompatibilität, die hohe thrombotische Aktivität und das damit verbundene Infektionsrisiko. 
Aus diesem Grund wurde in der vorliegenden Arbeit neben der Verbesserung der 
Biokompatibilität besonderer Wert auf die Reduzierung von Infektionen bei PET Implantaten 
gelegt. Wir konnten die Anhaftung von Bakterien deutlich reduzieren, und die Biokompatibilität 
von gekräuselten kardiovaskulären Implantaten aus gewebtem und gestricktem PET verbessern. 
Unsere Ergebnisse zeigen eine effiziente Möglichkeit durch Oberflächenmodifikation von 
Implantaten die Biokompatibilität dieser zu verbessern und ihre Resistenz gegen Infektionen zu 
erhöhen. 
 
Im Kapitel 2 konnte die primäre bakteriellen Adhäsion bei Infektionen durch einen 
netzwerkartigen multifunktionalen Oberflächenüberzug aus einem neu synthetisierten 
amphiphilen SD-PHA-b-MPEO Diblockcopolymer minimiert werden. Das beschriebene vielseitig 
anwendbare Beschichtungsverfahren basiert hierbei auf den Abstoßungskräfte zwischen der 
Oberfläche und dem verwendeten Polymer, um die Flexibilität und Reißfähigkeit des gekräuselten 
PET Transplantates zu erhalten. Das oberflächenmodifizierte Implantat wurde mittels Fourier-
Transformations-Infrarot-Spektroskopie (FTIR) und dem Rasterelektronenmikroskop (SEM) 
charakterisiert. Das eingesetzte Polymer manifestierte geeignete Biokompatibilität gegenüber 
dem Zielgewebe, was mit L929 Mausfibroblasten nachgewiesen werden konnte. Wichtig ist, dass 
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die negative Ladung und die hydrophoben Eigenschaften des Polymers die bakterizide Wirkung 
der Sulfadimethoxin-Einheit verstärkte. Diese wurde schon als signifikanter bakterieller Anti-
Adhäsionseffekt für grampositive S. aureus, gramnegativen E. coli Bakterien, sowie für die zuvor 
aus einer Vene isolierten grampositiven S. epidermidis berichtet. 
 
Im Gegensatz zu früheren Studien konnte im Kapitel 3 die bakterielle Adhäsion enzymatisch mit 
Hilfe des bakteriellen lytischen Enzyms Lysozym verhindert werden. Somit konnte ein  Implantat 
mit einer Breitspektrumresistentz gegen Bakterien entwickelt werden. Das Enzym Lysozym wurde 
kovalent auf dem PET Implantat durch die „end-point“ Methode immobilisiert und mittels FTIR- 
und Röntgenphotoelektronenspektroskopie (XPS) nachgewiesen werden. Die Aktivität des 
immobilisierten Lysozyms gegen M. lysodeikticus zeigte eine signifikante Reduktion im Vergleich 
zum freien Enzym. Allerdings reichte die Restaktivität aus, um die Adhäsion von grampositiven S. 
epidermidis und S. aureus Bakterien und in geringerem Maße von gramnegativen E. coli zu 
verringern. Der antiadhäsive Effekt war Bakterienzellen spezifisch, während keine signifikante 
Wirkung auf Adhäsion und Wachstum von L929 Zellen sichtbar war. Dies zeigte den Nutzen der 
verwendeten Strategie, um die anfängliche Adhäsion der Bakterien zu modulieren und die 
Implantat-assoziierte Infektion zu behindern. 
 
In Kapitel 4 wurden FITC-Dextran beladenen Poly-Milchsäure-Glykolsäure (PLGA)-Nanopartikel 
kovalent an zwei verschiedenen Herz-Kreislauf-Prothesen, nämlich gewebt gekräuselten PET und 
expandiertem Polytetrafluorethylen (ePTFE, Teflon ®), immobilisiert. Vor der Immobilisierung 
wurde die Implantate Oberfläche durch Einführung einer Aminogruppe an der Oberfläche 
aktiviert. Die so oberflächenmodifizierten Implantate wurden vor der kovalenten Bindung der 
PLGA-Nanopartikel über ihre Carboxylgruppe durch einen elektrokinetische Analysator und FTIR 
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charakterisiert. Das so hergestellte Modell wies eine homogene Monoschicht aus Nanopartikeln 
auf der Implantatoberfläche auf und zeigte eine zufriedenstellende Stabilität unter geeigneten 
menschenähnlichen kontinuierlichen Fließbedingungen innerhalb von 24 Stunden. Die erreichte 
Biokompatibilität der nanostrukturierte Implantatoberfläche ermöglicht bei Verwendung 
immobilisierter Nanopartikel an der Oberfläche einen vielversprechenden Therapieansatz für die 
lokale Arzneimittelabgabe, um die häufigsten Komplikationen nach dem Einsetzen des Implantates 
zu behandeln, und damit die Verträglichkeit langfristig zu verbessern. 
 
In Kapitel 5 wurde die thrombotische Aktivität  eine Implantat durch die kovalente 
Immobilisierung von Heparin reduziert. Zusätzlich wurde die Verträglichkeit der PET Implantate 
gegenüber dem Zielgewebe durch Co-Immobilisierung von Kollagen verbessert. Heparin und 
Kollagen wurden mittels „end-point“ Methode an die vorher funktionalisierten PET Implantate 
immobilisiert und mittels FTIR und XPS charakterisiert. Die modifizierten Implantate zeigten eine 
signifikante biologische Aktivität in vitro unter menschenähnlichen Bedingungen, insbesondere die 
Verminderung der Thrombus- und Fibrinbildung. Die Co-Immobilisierung von Heparin und 
Kollagen ist entscheidend für die Adhäsion und das Wachstum der Zielgewebezellen. Zusätzlich 
konnte ein synergistischer Effekt zur Verminderung der Thrombozytenanlagerung nach 30 min 
unter kontinuierlichen Fließbedingungen, die einen starken Blutfluss simulierten, gezeigt werden. 
Folglich minimiert dieser Ansatz die thrombotische Aktivität  der PET Implantate und die 
entsprechende Reaktion des Zielgewebes, wodurch eine rasche Besiedelung der Implantate mit 
Zellen des Zielgewebes erreicht wird, was für die Biokompatibilität erforderlich ist. 
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Abbreviation list 
AT III 
 
Anti-thrombin enzyme  
DMEM 
 
Dulbecco`s modified Eagle´s medium 
EBSS 
 
Earle`s balanced salt solution  
E. coli 
 
Escherichia coli 
EDC 
 
1-Ethyl-3-(3-dimethyl amidopropyl) carbodiimide hydrochloride  
ePTFE 
 
expanded Polytetrafluoroethylene  
ePTFE-OH 
 
expanded Polytetrafluoroethylene functionalized with hydroxyl group 
ePTFE-NH2 
 
expanded Polytetrafluoroethylene functionalized with amino group 
ePTFE-NPs 
 
Nano immobilized polytetrafluoroethylene 
FBS 
 
Fetal bovine serum  
FD 
 
Fluorescein isothiocyanate labeled dextran  
FTIR 
 
Fourier transform infrared spectroscopy 
MES 
 
2-(N-morpholino) ethanesulfonic acid  
M. lysodeikticus 
  
Micrococcus  lysodeikticus cells 
NPs 
 
Nanoparticles 
PBS 
 
Phosphate buffered saline 
PDI 
 
Poly dispersity index  
PET 
 
Polyethylene terephthalate 
PET-COOH 
 
Polyethylene terephthalate functionalized with carboxyl group 
PET-Enz 
 
Lysozyme immobilized polyethylene terephthalate 
PET-Hep 
 
Heparin immobilized polyethylene terephthalate 
PET-Hep-Col 
 
Heparin/collagen Co-immobilized polyethylene terephthalate 
PLGA 
 
Poly lactic-glycolic acid  
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PET-Net 
 
Network-structured coated Polyethylene terephthalate  
PET-NH2 
 
Polyethylene terephthalate functionalized with amino group 
PET-NPs  
 
Nano immobilized polyethylene terephthalate 
PRP 
 
Platelets-rich plasma  
PVE 
 
Prosthetic valve endocarditis  
PVGI 
 
Prosthetic vascular graft infection  
S. aureus  
 
Staphylococcus aureus 
SD 
 
Sulfadimethoxine  
SD-PHA-b-MPEO 
 
Sulfadimethoxine polyhexylene adipate-b-methoxy polyethylene oxide 
SEM 
 
Scanning electron microscope  
S. epidermidis 
 
Staphylococcus epidermidis 
Sulfo-NHS 
 
N-hydroxysulfosuccinimide,  
W1/O/W2 
 
Double emulsion water/oil/water 
XPS 
 
X-ray photoelectron spectroscopy 
Z-Ave 
 
Particle mean diameter 
ζ potential 
 
Average potential value  
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